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Abstract
Two North American ginseng extracts were used to test sexual behavior in healthy rats 
and pre-diabetic rats, with erectile dysfunction, after four weeks of oral administration. 
Behavioral tests assessed sexual performance while animal tissues were used to examine 
eNOS and nNOS protein and mRNA in central and peripheral sites known to control 
erectile function. Results show an improvement in erectile function during copulation in 
healthy rats with chronic treatment of ethanol extract of NA ginseng but not aqueous 
extract. In addition, eNOS and nNOS mRNA was increased in penile tissue and nNOS 
staining was increased in the paraventricular nucleus of the hypothalamus with acute 
treatment of ethanol extract. For pre-diabetic rats, ethanol extract improved erectile 
function during mating and penile reflex tests. Also, nNOS was increased in penile tissue 
with chronic treatment and eNOS with acute treatment. The results show NA ginseng 
ethanol extract can improve erectile function.
Keywords: North American ginseng, erection, ex copula, erectile dysfunction, diabetes, 
nitric oxide synthase, pavaventricular nucleus of the hypothalamus.
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1.1.1. Male Rat Sexual Behavior
Complex interactions of hormonal and neurochemical signals regulate the various 
aspects of male sexual behavior (Pfaus et al., 2001). Rats exhibit discontinuous sexual 
mating in comparison to the “locked” behavior of humans where physical contact and 
penetration are maintained until ejaculation (Pfaus, 2009). In summary, olfactory, tactile, 
and auditory cues from a receptive female stimulate desire and elicit a consummatory 
response from the male rats. The male will mount the female from the rear and perform 
several rapid pelvic thrusts; if no vaginal penetration occurs then the action is called a 
mount (Pfaus, 2009). If during a mount the male detects the female vagina and obtains an 
erection rigid enough for penetration, he will give one strong thrust and insert his penis; 
this is known as an intromission (Pfaus, 2009). After either a mount or an intromission 
the female darts away while the male dismounts and typically grooms his genitals; this 
gives rise to the discontinuous mating.
After a few seconds, the female will again display preceptive behavior to 
stimulate desire in the male (Beach, 1976). The male will continue to mount and intromit 
the female until ejaculation is reached when the male performs rhythmic thrusts and 
inserts a seminal plug into the vagina followed by a slow dismount (Pfaus, 2009). After
ejaculation, a post-ejaculatory interval (PEI) occurs for a few minutes where the male 
will not engage in sexual behavior; the PEI ends once the male successfully intromits the 
female (Clark, 1995).
The male will initiate another copulatory series if presented with a receptive 
female and will typically repeat five to ten copulatory series until satiation (Clark, 1995). 
Importantly, previous sexual experience facilitates the initiation and overall performance 
of male sexual behavior, as evidenced by decreased latencies to initiate sexual behavior 
and increased sexual performance (Balfour et al., 2004; Pitchers et al., 2010). Successful 
male sexual behavior is dependent on intact erectile function to maintain a penis rigid 
enough for vaginal penetration.
1.1.2. Experiments on Erectile Function
Many behavioral tests have been developed to determine the quality and quantity 
of erections in rats. During copulation, measurements for erectile function are evaluated 
based on mount and intromission frequency and copulation efficiency (CE) (Clark,
1995). CE is a ratio of the number of total successful intromissions to the number of total 
mounts and intromissions (Clark, 1995). In essence, CE is a measure of penile rigidity; it 
compares the amount of successful vaginal penetrations to the total number of attempted 
vaginal penetrations.
Simulated tests for erectile function have been developed to evaluate erections 
outside of copulation. Noncontact erections (NCE), also known as psychogenic erections 
in humans, are erectile responses initiated by sexual arousal (Sachs et al., 1994). In 
rodents, stimulation from receptive females in the form of olfactory, auditory, and tactile 
vibrations elicits erectile responses in male rats even without physical contact (Sachs et 
al., 1994). The male displays hallmark signs of erections based on rhythmic hip 
contractions and flexions while grooming his genitals (Sachs, 1996). The number or 
erections and timing to the first erection are measures of erectile function induced by 
arousal.
An additional method of examining erectile function is a reflexive test known as 
ex copula. During the test, rats are restrained in a supine position, the prepuce is retracted 
and light pressure is used to hold the penis in place and maintain prepuce retraction. Both 
tactile stimulation and prepuce retraction elicit erectile reflexes of varying magnitudes 
that can be analyzed for erectile function (Sachs and Garinello, 1978). In summary, three 
levels of erections occur. El erections occur when the base of the glans swells with 
blood, E2 erections occur when the tip of the glans swell with blood, and E3 erections 
occur when the tip of the glans swell so the circumference of the tip is greater than the 
base (Sachs and Garinello, 1978). Intracavemous pressure increases as the erectile reflex 
increases in number, indicating an increase in penile rigidity (Bemabe et al., 1995). In 
addition, penile flexions and clusters of erectile responses, which occur during ex copula 
tests can also be used to help measure erectile reflexes (Sachs and Garinello, 1978).
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1.1.3. Central Regulation of Penile Erection
Penile erections involve tumescence of the cavernous bodies by engorging them 
with blood when penile veno-occlusion occurs in conjunction with dilation of penile 
arteries (Giuliano and Rampin, 2004; Hidalgo-Tamola and Chitaley, 2009). Control of 
erection involves a complex interaction between sensory inputs and neural and peripheral 
systems (Argiolas and Melis, 2005). In humans, tactile, visual, and imaginative stimuli 
can initiate an erection, whereas in rodents, auditory and olfactory cues can also 
contribute to inducing erectile responses (Sachs, 2000; Steers, 2000). Although the neural 
control for erections originate in the spine, erections are under excitatory influences from 
supraspinal sites (Rosen and Sachs, 2000) such as the paraventricular nucleus of the 
hypothalamus (PVN; Figure 1).
Paraventricular Nucleus of the Hypothalamus: The PVN receives projections 
from the areas of the brain involved in male sexual behavior and sends oxytocin 
projections to extra-hypothalamic brain regions (Argiolas and Melis, 2005) 
(Figure 1.1). Importantly for modulating erections, the PVN is thought to be the 
only supraspinal brain region to send projections to the spinal cord to regulate 
erectile function (Argiolas and Melis, 2005). Stimulation of the PVN induces 
penile erections in animals (Melis et al., 1994; Chen and Chang, 2002, 2003). 
Lesions of the PVN have region-specific effects; lesions that incorporate both 
parvo- and magnocellular subregions of the PVN using radiofrequency show 
impairment on male copulation as indicated by increased mounts and ejaculatory
latency and a decreased number of NCE (Liu et al., 1997). However, lesions in 
the PVN using N-methyl-D-aspartic acid, which only destroys the parvocellular 
subregion, showed no impairment in copulatory performance but decreased the 
number of NCE (Ackerman et al., 1997; Liu et al., 1997). Activation of the 
oxytocin neurons in the PVN requires an intracellular increase in nitric oxide 
(NO) production through the activation of neuronal nitric oxide synthase (nNOS); 
however, the mechanism through which NO activates oxytocin neurons is 
currently unknown (Melis et al., 1998; Chen and Chang, 2002; Argiolas and 
Melis, 2005). In conclusion, the PVN plays a supportive, non-essential role in 
erectile function and is thought to be the only supraspinal region with connections 
to the spinal cord that contributes to the regulation of erections.
1.1.4. Peripheral Control of Penile Erection
Upon appropriate appetitive stimulation, projections from the central nervous 
system increase the parasympathetic tone and decrease the sympathetic output of nerves 
in the penis (Andersson, 2001). Specifically, parasympathetic stimulation activates 
nonadrenergic-noncholenergic (NANC) nerves, which increases nNOS activity that 
further increases NO release into the vasculature. NO is vital for tumescence in erectile 
tissue (Rajfer, 2008). NO then enters the smooth muscle cells to activate soluble 
guanylate cyclase (sGC) and increase its production of cyclic guanosine monophosphate 
(cGMP) (Giuliano and Rampin, 2004). cGMP then causes a cascade of events leading to 
the hyperpolarization and relaxation of the smooth muscle cells and, consequently, the
6
Modified from (Melis and Argiolas, 2010)
Figure 1.1. Schematic diagram of the paraventricular nucleus of the hypothalamus with 
oxytocinergic projections. Oxytocinergic projections to the spinal cord are thought to be 
the only projections to the spinal cord that regulate erectile function.
engorgement of cavernous bodies to form an erection (Rajfer et al., 1992). cGMP can be 
inactivated to 5’-cGMP by phosphodiesterase type 5 (PDE5) in the penile tissue 
(Rybalkin et al., 2003). Consequently, PDE5 has become a pharmacological target for 
men with erectile dysfunction (ED).
Shear pressure in the endothelial cells of the penile vasculature increase NO 
production from endothelial nitric oxide synthase (eNOS), which also contributes to the 
activation of sGC in smooth muscle cells (Hidalgo-Tamola and Chitaley, 2009). 
Production of NO via nNOS is seen as the initiator of erections while eNOS is viewed as 
the maintainer of erections since an increase in intracavemous pressure is required before 
eNOS increases its NO production (Gratzke et al., 2010).
Proper erectile function can deviate from healthy conditions at many areas in the 
central and peripheral erectile pathways. Moreover, ED can occur through psychological 
and cardiovascular pathological states; however, there is no consensus on the mechanism 
of ED development (Rosen et al., 2004). Furthermore, it is likely that a combination of 
alterations contribute to the development of ED in both healthy and diabetic patients.
1.2.1. Erectile Dysfunction
The prevalence of ED varies based on the population analyzed, the methods of 
assessing ED, and the threshold used to classify a patient with ED (Prins et al., 2002). 
Regional variation with identical screening methods of men between the age of 20 to 75
shows a range of ED prevalence between 10 to 22% (Rosen et al., 2004). Overall, 
approximately 16% of men experience ED; prevalence of ED increases with age, high 
blood pressure (26%), cholesterolemia (26%), depression or anxiety (26%), and diabetes 
(39%). Of this population, 58% seek treatment and only 16% who are prescribed PDE5 
inhibitors, such as Sildenafil (Viagra), actively use the drug (Rosen et al., 2004). In 
addition, not all men respond positively to PDE5 inhibitors. Only 56% of men with Type 
2 diabetes mellitus (T2DM) respond to treatment as compared to 86% of the general 
population (Rendell et al., 1999). Also, after a year of PDE5 treatment, men who 
responded positively to PDE5 inhibitors may revert back to pre-treatment conditions 
(Penson et al., 2003).
1.2.2. Erectile Dysfunction in Type 2 Diabetes Mellitus
Development of ED can occur when the NO/cGMP pathway in penile tissue is 
disrupted. Diabetes can negatively affect multiple mechanisms through which normal 
erectile function occurs: impaired vasodilatory signalling through NANC dysfunction 
and/or endothelial damage, oxidative stress, hypogonadism, and veno-occlusive 
dysfunction, to name a few (Hidalgo-Tamola and Chitaley, 2009).
Although NANC dysfunction is established in Type 1 diabetes mellitus (T1DM), 
the role of NANC dysfunction in T2DM is still unclear due to conflicting results from 
different studies. In mice, no significance was reported between control and T2DM mice 
in regards to NANC dysfunction; however, Otsuka Long Evans Tokushima Fatty
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(OLETF) rats, as a model of T2DM, presented with decreased nNOS immunofluorescent 
staining in penile nerves and a 40% reduction in nNOS protein expression (Vemet et al., 
1995; Hidalgo-Tamola and Chitaley, 2009). In addition to NANC dysfunction, loss of 
endothelial NO production may contribute to the pathological state of impaired penile 
vasodilation. Decreased immunofluorescent staining and protein expression of eNOS was 
found in OLETF rats (Jesmin et al., 2003). Given the discrepancy in NANC dysfunction 
and the limited studies on T2DM endothelial function, further experiments are needed to 
verify any decrease in NO production in T2DM models.
In diabetes, the chronic state of hyperglycemia causes inflammation and an 
increase in the formation of reactive oxygen species (ROS), such as superoxide anions 
(Gur et al., 2009). Superoxide anion reacts with NO to form peroxynitrite, which is 
another ROS. Peroxynitrite is pro-apoptotic and causes vascular damage to small penile 
resistance arteries causing endothelial apoptosis, which decreases the contribution of NO 
from eNOS (Jeremy et al., 2007). ROS also contribute to ED by scavenging the 
vasculature for NO, causing a direct decrease in its bioavailability to cause vasodilation 
(Hidalgo-Tamola and Chitaley, 2009). In addition, the antioxidant glutathione, which 
reduces ROS, is decreased in hyperglycaemic conditions (Gur et al., 2009). As such, 
diabetic populations experience an increase in oxidative stress as well as a decrease in 
antioxidant levels to combat oxidative stress.
Men with both ED and T2DM have a higher prevalence of hypogonadism; 
approximately 25% of men with both pathologies experience hypogonadism compared to
less than 13% in men with ED who are not diabetic (Corona et al., 2004; Corona et al., 
2006). Adipose tissue converts androgens to estrogens via aromatase, which causes an 
overall decrease in testosterone levels (Hidalgo-Tamola and Chitaley, 2009). 
Testosterone has an important role in regulating both erectile function and male sexual 
libido; severely decreased testosterone levels can lead to a reduction in both parameters 
(Mills and Lewis, 1999; Gray et al., 2005).
Finally, T2DM rats inadequately maintain intracaveronsal pressure after saline 
infusion indicating veno-occlusive dysfunction in penile tissue (Kovanecz et al., 2006). 
Indeed, studies have shown that 39-67% of patients with T2DM experience veno- 
occlusive dysfunction (Colakoglu et al., 1999; Metro and Broderick, 1999). In 
conclusion, treatment of diabetic patients with ED may require combination therapies 
since PDE5 inhibitors alone may not provide adequate pro-erectile treatment and the 
combined secondary effects of diabetes decreases erectile capacity.
1.2,3. The Obese Zucker Rat: A Model of Pre-Diabetes
Even though 90% of DM patients are categorized with T2DM, previous studies 
focus on T1DM animals models (Hidalgo-Tamola and Chitaley, 2009). The Obese 
Zucker (OZ) rat is a model for pre-diabetes with similar pathologies as T2DM. OZ rats 
have an autosomal recessive mutation in the leptin gene and are glucose intolerant 
(Kasiske et al., 1992). Also, similar to T2DM patients, OZ rats have hyperinsulinemia, 
insulin resistance, hyperlipidemia, obesity, hypertension, and impaired vasodilation
(Kasiske et al., 1992). These secondary pathologies of pre-diabetes contribute to ED 
development in OZ rats (Edmonds and Withyachumnamkul, 1980; Edmonds et al., 1982; 
Withyachumnamkul and Edmonds, 1982; Doherty et al., 1985; Hemmes and Schoch, 
1988).
Male OZ rats have a decrease in intromission latency (Withyachumnamkul and 
Edmonds, 1982), intromission frequency (Doherty et al., 1985), and ejaculation latency 
(Doherty et al., 1985). The OZ rat is a good model for testing pharmacological therapies 
for ED because diabetes is not fully established and the secondary effects of diabetes on 
erectile function are not completely manifested to potentially cause irreversible ED. 
However, it is not uncommon for the sexual performance of older OZ rats to be so 
severely impaired that they do not copulate (Young et al., 1986).
1.3.1. Ginseng Plant
The ginseng genus is composed of a minimum of nine species including Panax 
ginseng (Asian ginseng) and Panax quinquefolius (North American (NA) ginseng) 
(Leung and Wong, 2010). Ginseng plants are perennial herbs that have been used for 
millennia as health tonics either alone or in combination with other medicinal ingredients 
(Attele et al., 1999) (Figure 1.2). Ginsenosides are considered the main, active, medical 
constituent in the ginseng genus and were first isolated in 1963 (Shibata et al., 1963). 
Ginsenosides are triterpene saponins with a dammarane skeleton consisting of multiple 
sugar moieties; they possess a rigid four trans-ring steroid skeleton
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Modified from: http://www.wildcrafting.net/forage/plant/129/
Figure 1.2. Photograph of Panax quinquefolius
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(Shibata et al., 1965; Leung and Wong, 2010). In NA ginseng, ginsenosides Rbl, Re, Rd, 
Re, Rgl, and Rb3 constitute more than 70% of the total ginsenoside content and provide 
a basis to standardize NA ginseng extracts (Lim et al., 2005; Wang et al., 2005). 
Ginsenoside Rf is found exclusively in Asian ginseng and can be used as a marker to 
distinguish Asian from NA ginseng (Li et al., 2000). Importantly, differing effects on 
angiogenesis and immunomodulation have been reported based on the solvent used to 
create the ginseng extract (Azike et al., 2011).
As a general health tonic, ginseng has traditionally been used to treat multiple 
pathological states. It is rationalized that the ginseng plant can be used as a health tonic 
since it contains more than 20 ginsenosides and each ginsenoside may cause differing 
effects on certain receptors or tissues (Attele et al., 1999). However, the ginsenoside 
content in ginseng root extracts varies by species, age, cultivation practise, time of 
harvest, and manufacturing methods (Lim et al., 2005; Schlag and McIntosh, 2006).
Thus, developing crops with consistent ginsenoside contents is difficult. In response, 
creating a composite extract from multiple farming locations can help minimize 
variability of ginsenosides. In addition, recent studies are indicating polysaccharides in 
the ginseng root may contribute to some of the medicinal qualities of ginseng (Wang et 
al., 2010a).
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1.3.2. Ginseng Treatment for Enhancing/Rescuing Erectile Function
Among its many uses as a health tonic and “adaptogen”, ginseng has been used 
for millennia as a natural aphrodisiac in men. Recently, the scientific literature has begun 
to support this claim. Various animal models have been used to examine the effects of 
ginseng extracts on male sexual performance. Tests on Asian and Korean Red ginseng 
(the steamed form of Asian ginseng) have used humans (Hong et al., 2002; de Andrade et 
al., 2007; Jang et al., 2008; Kim et al., 2009), rats (Kim et al., 1976), mice (Yoshimura et 
al., 1998), and rabbits (Choi et al., 1999). In addition, one study examined the effects of 
ginsenoside Rgl on copulatory behavior in mice (Wang et al., 2010b) and another study 
used NA ginseng on rats (Murphy et al., 1998).
Studies on sexual performance in humans using Asian ginseng show an increase 
in erectile function as indicated by a self reporting questionnaire called the International 
Index of Erectile Function (IIEF). Tests indicate that ginseng treatment was able to 
improve scores on penetration, erection maintenance, and rigidity in men with ED after 
12 weeks of treatment (de Andrade et al., 2007). In addition, after 8 weeks of treatment 
penile rigidity in men with ED was increased upon auditory and visual stimulation, as 
indicated by the RigiScan test (Hong et al., 2002). However, a systemic review indicates 
that although chronic ginseng treatment shows promise for treating ED in humans, more 
studies are required to draw definitive conclusions (Jang et al., 2008).
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Animal studies indicate ginseng can be used to increase erectile function (Choi et 
al., 1999) as well as increase male sexual performance during mating (Kim et al., 1976; 
Murphy et al., 1998; Yoshimura et al., 1998; Wang et al., 2010b). In summary, 
electrostimulation of pelvic nerves in rabbits treated for three months with Korean Red 
ginseng caused an increase in intracavemous pressure, indicating increased penile rigidity 
(Choi et al., 1999). This occurred with an increase in relaxation of penile muscles to 
acetylcholine in ginseng-treated rabbits compared to control animals (Choi et al., 1999). 
Regarding sexual performance, ginseng treatment was able to enhance mating behavior in 
mice and rats with (Yoshimura et al., 1998) and without (Kim et al., 1976) impaired 
performance, respectively. Furthermore, sexual arousal was enhanced with NA ginseng 
treatment in healthy rats as indicated by decreased latencies to mount, intromit, and 
ejaculate (Murphy et al., 1998). The increase in sexual arousal occurred after 14 days of 
ginseng treatment and persisted until 28 days of treatment alongside reductions in 
circulating prolactin levels (Murphy et al., 1998). The authors conclude that increased 
dopaminergic activity in the central nervous system caused a decrease in prolactin levels, 
which they correlate to increased male rat copulatory behavior (Murphy et al., 1998). 
However, this may not translate to humans since Korean Red ginseng treatment has not 
been shown to influence prolactin levels (de Andrade et al., 2007).
Finally, ginsenoside Rgl increased male mice copulatory behavior after 20 days 
of treatment (Wang et al., 2010b). In addition, Rgl increased plasma testosterone as well 
as cGMP and NO levels in penile tissue (Wang et al., 2010b). However, testosterone 
levels were reported to be unchanged with NA ginseng treatment in rats (Murphy et al.,
1998) and with Korean Red ginseng treatment in humans (de Andrade et al., 2007). As 
such, further tests are required to clarify hormone changes in plasma with ginseng 
treatment regarding male sexual behavior.
With regards to penile erectile function, experiments in vitro (Chen and Lee,
1995; Rimar et ai., 1996) and in vivo (Lee et al., 1981) show the vasodilatory effect of 
ginseng on the vasculature. In particular, Asian ginseng extract applied to rabbit corpus 
cavemosum caused a dose-dependent vasodilatory effect, which was enhanced with 
superoxide dismutase and abolished by a NOS inhibitor (Chen and Lee, 1995). These 
results indicate a role of NO in the vasodilatory effects of ginseng in the penile 
vasculature.
In addition, as previously stated, the maintenance of healthy endothelial cells in 
the vasculature is imperative to proper erectile function. Ginseng has been shown to 
possess antioxidant properties (Kim et al., 1992; Gillis, 1997) that would protect 
endothelial cells from oxidative stress in pathological conditions such as diabetes 
(Hidalgo-Tamola and Chitaley, 2009). Moreover, the use of ginseng may provide diabetic 
patients with the needed boost in antioxidant levels to protect the endothelial cells from 
ROS and provide pro-erectile effects by activating the NO/cGMP pathway.
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1.4. Objectives and Hypothesis
The overall goal of this study is to determine the effects of NA ginseng extracts 
on sexual performance and erectile function in healthy (chapter 2) and pre-diabetic 
(chapter 3) male rats. While ginseng has shown promise in enhancing male sexual 
function, further studies are needed to validate this claim. In addition, only one study has 
been published examining the effects of NA ginseng on male sexual performance by 
analyzing measures for sexual arousal. The study by Murphy and colleagues did not 
measure effects of NA ginseng on erectile function. As such, further studies are needed to 
determine potential effects of NA ginseng at enhancing erectile function in healthy 
models and potential effects of NA ginseng at improving sexual behavior in ED. The 
mechanisms by which ginseng acts to elicit pro-erectile effects remains largely 
unexplored, although evidence thus far indicates increased activity in the NO/cGMP 
pathway and increased ROS scavenging (Kim et al., 1992; Chen and Lee, 1995; Gillis, 
1997). We hypothesize that NA ginseng will increase sexual performance in healthy rats 
and partially recover erectile function in pre-diabetic rats by acting on the NO/cGMP 
pathway. In addition, we will investigate expression of NOS in pro-erectile brain areas in 
healthy rats. Indeed, ginseng has been shown to act centrally to produce effects such as 
memory enhancement (Nah et al., 2007; Radad et al., 2010). Another objective of this 
study is to examine two common ginseng extract preparations, ethanol and aqueous, to 
help determine preparation differences and help hypothesize on the active constituents in 
NA ginseng that enhance male sexual performance.
Finally, effects of NA ginseng administration on anxiety-like behaviors will be 
conducted to determine if effects on sexual behavior are occurring secondary to negative 
effects on this parameter. Currently, chronic administration of Asian ginseng is not 
known to influence anxiety-like behaviors; however, acute administration of Asian 
ginseng at high doses has been shown to decrease anxiety levels (Carr et al., 2006; Einat, 
2007). Also, for the same reasons as testing anxiety levels we will test the rewarding or 
aversive properties of NA ginseng.
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Chapter 2: North American ginseng improves erectile function and increases nitric 
oxide synthase in penile tissue and hypothalamus of male rats.
2.1. Introduction
Erectile function is a complex interplay of physiological and psychological 
factors. Prevalence of erectile dysfunction (ED) varies widely with select sample 
populations but estimates range from 12% (Martin-Morales et al., 2001) to 22% 
(Laumann et al., 1999) in men from 20 to 75 years of age. The prevalence of ED greatly 
increases with co-morbid medical conditions and risk factors such as coronary artery 
disease and diabetes (Rosen et al., 2004). Even though great advances have been made 
towards ED treatment, only 58% of ED patients seek treatment and only 16% who are 
prescribed phosphodiesterase type 5 (PDE5) inhibitors, such as Sildenafil, actively use 
the drug (Rosen et al., 2004). In addition, not all men respond positively to PDE5 
inhibitors, especially those with co-morbidities, and will discontinue its use when 
expectations are not met (Azadzoi and Saenz de Tejada, 1992; Goldstein et al., 2003; 
Jiann et al., 2006). Hence, there is continued need for additional ED treatments.
Ginseng has been used for millennia as a natural aphrodisiac. The two most 
common species of ginseng are Panax ginseng (Asian ginseng) and Panax quinquefolius 
(North American [NA] ginseng). Both species have unique ginsenoside profiles (Wan et 
al., 2007; Sun et al., 2011), which are the main active constituents. Several studies have
shown effects of Asian and Korean ginseng on male rat and mouse sexual behavior 
(Murphy et al., 1998; Yoshimura et al., 1998; Choi et al., 1999). These studies have 
shown decreases in mount and ejaculation latencies upon ginseng administration and 
restoration of mating behavior in mice with copulatory disorders. Also, Asian ginseng 
extracts have been shown to cause vasodilation in canine corpus cavemosum (Kang et 
al., 2005), rabbit corpus cavemosum (Chen and Lee, 1995), as well as smooth muscle 
cells in rat aorta (Kim et al., 1999). However, few studies have been conducted using NA 
ginseng. In one study, chronic NA ginseng treatment facilitated sexual behavior in male 
rats by decreasing mount, intromission, and ejaculatory latencies (Murphy et al., 1998). 
The current study expanded on these previous findings by examining the effects of NA 
ginseng, using two different extraction methods, on male sexual behavior in young adult 
rats. In addition, effects on male erectile function and sexual arousal were examined in 
models where an estrus female was physically inaccessible.
Finally, the third goal of the study was to elucidate potential sites of action by 
which NA ginseng can improve sexual behavior. It has been well established that nitric 
oxide (NO) is a major cellular mediator of erectile function via vasodilation in the corpus 
cavemosum in penile tissue (Rajfer, 2008). NO activates soluble guanylate cyclase which 
increases cyclic guanosine monophosphate (cGMP) levels, causing a cascade of events 
leading to relaxation of smooth muscle cells and tumescence (Rajfer et al., 1992). It is 
hypothesized that NA ginseng improves sexual function by increasing NO signalling in 
erectile tissues. Indeed, ginsenoside Rgl, present in Asian and NA ginseng, increases NO 
and cGMP levels in corpus cavemosum of male mice treated for 20 days (Wang et al.,
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2010b), which supports the hypothesis. Hence, effects of NA ginseng on expression of 
nitric oxide synthase (NOS) in erectile tissue will be determined.
Moreover, NA ginseng may influence sexual behavior by acting on the central 
nervous system. The central control of male erectile and sexual function derives from a 
neural circuit including the paraventricular nucleus of the hypothalamus (PVN) 
(McKenna, 2000; Giuliano and Rampin, 2004). In the PVN neuronal activation of 
oxytocin neurons has been implicated with male erectile function (Argiolas and Melis, 
2005). Neuronal nitric oxide synthase (nNOS) is required for the activation of oxytocin 
neurons in the PVN (Melis et al., 1998). Effects of NA ginseng on the PVN have not yet 
been established. Therefore, the final goal of this study was to examine effects of NA 
ginseng on nNOS expression in the PVN.
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2.2. Methods and Materials
2.2.1. Animals
Adult, male Long Evans rats (200-250 g) were delivered from Charles River 
(Sherbrooke, Quebec, Canada) and housed in pairs in Plexiglas cages. Rats were placed 
under a 12/12 reversed light-dark cycle with lights off at 10 a.m. Food and water were 
available ad libitum. Female Long Evans rats (Charles River) were bilaterally 
ovariectomized and subcutaneously implanted with a capsule containing 5% 17-|3- 
estradiol benzoate (Sigma, St. Louis, Missouri, USA) and 95% cholesterol (Sigma, St. 
Louis, Missouri, USA). To induce sexual receptivity, females were injected (s.c.) with 
500 mg progesterone dissolved in 0.1 mL sesame oil (Sigma, St. Louis, Missouri, USA) 
four hours prior to experiments. All procedures were approved by the Animal Care 
Committee at the University of Western Ontario and conform to the guidelines of the 
Canadian Council on Animal Care (Ottawa, Ontario, Canada).
2.2.2. North American Ginseng Extracts and Administration
Ginseng extracts were prepared from the roots of four-year-old NA ginseng plants 
harvested from five farms in Ontario, Canada, which were provided by the Ontario 
Ginseng Grower’s Association and processed by Naturex (South Hackensack, New 
Jersey). Roots were ground and soaked at 40°C three times for a total of five hours in 
either ethanol/water (75/25%) or aqueous solutions. The extracts were filtered and excess
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solvent was removed at 45°C until total solid content reached 60%. Ethanol and aqueous 
NA ginseng root extracts were prepared after lyophilization at the Ontario Ginseng 
Innovation and Research Consortium (University of Western Ontario, London, Canada). 
The concentration of the major ginsenosides (Rbl Re, Rgl, Rb2, Rd, and Rc) for both 
extracts have previously been determined by high-pressure liquid chromatography (Azike 
et al., 2011).
Ginseng extracts were suspended in 0.9% saline and were injected daily to the rats 
via oral gavage two to three hours after lights off under red light illumination. Rats were 
randomly assigned to experimental groups and received one of two dosages of ethanol 
extract (125 or 250 mg/kg/day) or aqueous extract (125 or 250 mg/kg/day) or vehicle 
(0.9% saline). The volumes of all oral injections were adjusted so that less than 1 mL of 
fluid was administered per day. Average weight of treatment groups did not differ at the 
start of experiment. Male rats administered daily aqueous or ethanol extracts did not 
differ in weight gain at any time point compared to control male rats administered saline 
(data not shown).
2.2.3. Sex Behavior Analysis
Following 28 days of daily NA ginseng (ethanol or aqueous) or vehicle 
administration, males were tested for sexual behavior every other day during four tests. 
Males were sexually naive prior to onset of experiments, thus, effects of NA ginseng on 
mating were determined in males when sexually naive and experienced. In addition,
effects of NA ginseng on mating were determined either shortly following NA ginseng 
administration or one day following last injection. For tests 1 and 3, males received NA 
ginseng or vehicle 30 minutes prior to mating, while tests 2 and 4 were conducted 24 
hours following last injection. During all tests, male rats were placed in a clean test cage 
(with clean bedding; 60 x 45 x 50 cm3) 10 minutes prior to introduction of a receptive 
female, and were allowed to mate to one ejaculation (and completed a post-ejaculatory 
interval; PEI) or for one hour, whichever came first. All standard parameters of male 
sexual performance were recorded including: mount latency (ML; time from introduction 
of a female until the first mount), intromission latency (IL; time from introduction of a 
female until the first mount with successful vaginal penetration), ejaculation latency (EL; 
time from the first intromission of a female until ejaculation), PEI (time from ejaculation 
to first subsequent intromission), number of mounts (M), and intromissions (IM) prior to 
first ejaculation, and copulation efficiency (CE; ratio of number of intromissions to total 
number of mounts). Differences between groups were compared using two-way ANOVA 
(factors: test and treatment) and Student-Newman-Keuls t-test for post hoc analysis with 
95% confidence levels (SigmaPlot version 11.0).
2.2.4. Non-Contact Erections
Next, following 36 days of daily NA ginseng or vehicle administration, male rats 
(sexually experienced) were tested for non-contact erections (NCE); a paradigm for 
psychogenic erections (Sachs and Garinello, 1978). The NCE apparatus consisted of two 
same-sized compartments with clear walls, ceiling, and floors separated by a perforated
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screen (MED Associates Inc., St. Albans, Vermont, USA). Experimental design was 
adapted from Sachs (Sachs, 1996). Briefly, males were habituated in the apparatus for 
five minutes one day prior to testing. On the test day, male rats were injected with NA 
ginseng 30 minutes prior to the experiment in the second half of the dark phase. Male rats 
were then placed in one compartment with an estrus female in the other compartment. A 
fan was placed behind the female to blow odors towards the male. The behavior was 
recorded for 20 minutes using digital cameras (Samsung Seoul, South Korea; Sony, 
Tokyo, Japan) and the latency to first erection and the number of erections were 
measured. Erections were scored if the rat displayed one of three criteria: 1) visible 
erection, or the male rat displays genital grooming with one of the two following 
behaviors; 2) hip contractions or; 3) hip flexions. Differences between groups were 
compared using one-way ANOVA and student t-tests for post hoc analysis with 95% 
confidence levels.
2.2.5. Additional Behavioral Tests
Although the main goal of the study was to test the effects of NA ginseng on 
sexual behavior and erectile function, additional tests were performed to determine 
potential effects of NA ginseng on anxiety-like behaviors and to determine rewarding or 
aversive properties. Moreover, ethanol or aqueous-treated animals were tested in 
conditioned place preference (CPP) paradigm, elevated plus maze (EPM), and open field 




2.2.5.I. Conditioned Place Preference Paradigm
Fourteen days after daily NA ginseng or vehicle injections, rats were tested for 
rewarding or aversive properties of NA ginseng using the CPP paradigm as described by 
Di Sebastiano et al. (Di Sebastiano et al., 2011). Briefly, the CPP apparatus (MED 
Associates Inc., St. Albans, Vermont, USA), consisted of three chambers that differ in 
visual and tactile cues: two test chambers (28 x 22 x 21 cm) with either black walls and 
parallel bar flooring or white walls and metal grid flooring, and a central, neutral 
compartment (13 x 22 x 21 cm) with grey walls and a smooth Plexiglas floor. Chambers 
were connected by solid guillotine doors and equipped with photobeam arrays to record 
time in each chamber. During the pre-test, male rats were allowed to freely roam the CPP 
apparatus for 15 minutes to establish individual chamber preferences for each rat. The 
apparatus is unbiased and, as a group, rats do not display a preference for any chamber. 
Subsequently, during two conditioning days, rats received either NA ginseng or saline 
and were placed in the paired (initially non-preferred) or unpaired (initially preferred) 
chambers, respectively, for 30 minutes in a counter-balanced manner. During the post­
test, rats were allowed to freely roam the apparatus for 15 minutes to determine a place 
preference. A preference score (percentage of time spent in the ginseng-paired chamber) 
and difference score (time in paired chamber minus time in unpaired chamber) was 
calculated for each animal. Differences between pre- and post-tests scores were analyzed 
using paired t-tests with 95% confidence levels.
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2.2.5 2 . Elevated Plus Maze (EMP)
After 24 days of daily NA ginseng or vehicle administration, male rats were tested 
on the EPM (MED Associates Inc., St. Albans, Vermont, USA), 24 hours after last NA 
ginseng or vehicle injection and during the second half of the light phase. The EPM 
apparatus consisted of four arms elevated 75 cm from ground level, each 50 cm in length 
extending from a central junction, equipped with photobeam arrays to record activity.
Two arms were enclosed by black siding 40 cm high, while the other two arms were 
unenclosed. Male rats were placed in the center junction and allowed to roam the 
apparatus for 5 minutes. Differences between groups were compared using one-way 
ANOVA and student t-tests for post hoc analysis with 95% confidence levels.
2.2.5.3. Open Field
One day after the EPM test, rats were tested in an open field apparatus 24 hours 
after last NA ginseng or vehicle injection and during the second half of the light phase. 
Rats were placed in the open filed apparatus (40.5 x 40.5 cm; equipped with 16x16 
photobeam arrays; MED Associates Inc., St. Albans, Vermont, USA) for 20 minutes. 
Total ambulatory distance and resting time were recorded along the perimeter and in the 
center of the chamber. Differences between groups were compared using one-way 
ANOVA and Dunn’s Method for post hoc analysis with 95% confidence levels.
2.2.6. Tissue Collection
After completion of all behavioral tests, brains, blood, and penile tissues were 
collected to determine effects of NA ginseng on cellular mediators of erectile function. 
Effects of aqueous extract were not determined, based on observed lack of effects of this 
extract on sexual function (see results). Male rats chronically treated with NA ginseng or 
vehicle received a final administration of vehicle or NA ginseng (250 mg/kg), creating 
four groups. One hour later, males were anaesthetised with sodium pentobarbital (270 
mg/mL/kg), and blood samples (collected in centrifuge tubes coated with heparin; 
Pharmaceutical Partners of Canada Inc., Richmond Hill, ON, Canada) and penile tissue 
were collected and immediately frozen and stored at -80 °C. Rats were then transcardially 
perfused with 500 mL of 4% paraformaldehyde (PFA) in 0.1 M phosphate buffer. Brains 
were removed and post-fixed for one hour in PFA and then subsequently transferred to 
20% sucrose solution. Brains were cut coronally at 35 pm on a freezing microtome 
(Thermo Fisher Scientific, Walldorf, Germany) and collected in four parallel series in 
cryoprotectant solution (30% sucrose in 0.1 M PB with 30% ethylene glycol and 0.01% 
sodium azide) and stored at -20°C.
2.2.7. Immunohistochemistry
All procedures were performed under gentle agitation at room temperature. 
Sections were washed in 0.1 M saline-buffered sodium phosphate (PBS) between all 
incubation steps. Sections were incubated in H2 O2 (1% in PBS; 10 minutes), incubation 
solution (PBS solution containing 0.1% bovine serum albumin (BSA; Fisher Scientific,
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Fair Lawn, New Jersey, USA) and 0.4% Triton-X-100 (Fisher Scientific, Fair Lawn, New 
Jersey, USA); 1 hour), and then in primary antibody recognizing nNOS (rabbit anti- 
nNOS; Lot #24287; 1:40,000, DiaSorin, Saluggia, Italy) dissolved in incubation solution 
for 17 hours.
Next, sections were incubated with biotinylated goat anti-rabbit (1:500 in 
incubation solution, Vector Laboratories, Burlingame, CA, USA; 1 hour) and avidin 
horseradish peroxidase complex (ABC; 1:1,000 in PBS, Vector Laboratories; 1 hour). 
Reaction product was visualized with nickel-enhanced diaminobenzidine (DAB; 0.02% 
in 0.1 M PB containing 0.012% H20 2 and 0.08% nickel sulfate; Sigma, St. Louis, MO;
10 minutes). Finally, sections were mounted on plus-charged glass slides (Fisher 
Scientific, Fair Lawn, New Jersey, USA) and coverslipped with dibutyl phthalate xylene 
(DPX; Electron Microscopy Science, Hatfield, PA, USA).
2.2.8. Densitometry analysis for nNOS
nNOS immunoreactivity was analyzed bilaterally in the PVN (Bregma -1.80mm, 
nNOS: 1248 x 946 pixels). All images were taken under brightfield illumination using 
Optronics camera (Optronics Goleta, California, USA) and Neurolucida software. All 
images were taken together under the same magnification (using 20x objectives) and 
camera settings. Each area of analysis was defined using unique landmarks specific for 
the region (Paxinos and Watson, 1998). Density analyses of immunoreactive neurons 
were measured by calculating a threshold based on a mean gray value of all the images
and then determining the number of pixels above the threshold, expressed as the 
percentage of the analyzed area using ImageJ (National Institute of Health, Bethesda,
MD, USA). For each brain region analysed, two images were analyzed and averaged per 
animal. Differences between groups were compared using two-way ANOVA (factors: 
chronic treatment and last injection) and Student-Newman-Keuls for post hoc analysis 
with 95% confidence levels.
2.2.9. RNA isolation and real time PCR
Penile tissues from Long Evans male rats were homogenized in TriZol reagent 
(Invitrogen, Burlington, Ontario, Canada) for total RNA isolation. To establish the 
260/280nm absorbance ratio between 1.8 and 2.0, RNA quantity and purity were assessed 
using a NanoDrop spectrophotometer (ND 1000 v3.3.0; NanoDrop Technologies, Inc., 
Wilmington, DE). High Capacity cDNA Reverse Transcription Kit from Applied 
Biosystems Inc. was used to perform cDNA synthesis according to manufacturer’s 
instructions (Foster City, CA). nNOS and eNOS gene expression were then quantified by 
qRT-PCT. All reactions contained 2pL of cDNA, lOpL of TaqMan Universal PCR 
Master Mix 2X (Applied Biosystems, Foster City, CA), 0.8pL of 25mM MgCl2 
(Invitrogen, Burlington, ON), 6.2pL DEPC treated water and lpL of TaqMan gene 
expression assay solution for the gene of interest (nNOS Assay ID: Rn00583793_ml; 
eNOS Assay ID: Rn02132634_sl). Glyceraldehyde-3-phosphate dehydrogenase 
(GAPDH) (Assay ID: Rn99999916_sl) was used for an endogenous control. Samples 
were assayed in triplicate using the Rotor Gene RG 6000 Thermocycler and software 
(Corbett Life Sciences, San Francisco, CA) with cycling conditions of: hold at 50°C for 2
38
39
min and 95°C for 10 min, 40 cycles of 95°C for 15 sec and 58°C for 1 min. A standard 
curve was generated from qRT-PCR data for each gene to quantify gene expression. 
Penile cDNA reverse transcribed from RNA was used to create a standard curve with 5-
log serial dilutions. Optimal standard curves were achieved only when the line of best fit 
of cycle threshold (C,) values of dilutions had a R2 > 0.99 and an efficiency value 
between 0.8-1. Each gene's optimal threshold line from the standard curve was used to 
determine the Ct value of each sample, which were determined from the intersection 
between the baseline subtracted amplification curve of the sample and the threshold line 
established by the optimal standard curve. For each experiment sample, the Ct value for 
each gene of interest was normalized to their respective Ct value of GAPDH, thus, 
generating the ACt value. In addition, AACt values (= 2A(ACt(Sampie) - ACt(average))* 100 ) 
were calculated using the difference between the ACt value for each individual sample in 
the treatment groups and the average ACt value of the control group. Two-way ANOVA 
with Holms Sidak post hoc analysis were conducted to identify significant differences 





Administration of ethanol extract of NA ginseng significantly affected expression 
of sexual behavior. There was a significant effect of treatment on the numbers of mounts 
and intromissions, copulation efficiency, and inter-intromission interval (F(2,209)=3.3- 
166; p=0.041-0.001) (Figure 2.1). Effects of trials were not detected for these 
parameters of sex behavior except for number of intromissions (F(3, 209)=3.8; p=0.011). 
Post hoc analyses revealed that number of mounts were significantly lower following 
treatment of either of the two dosages compared to saline in mating trails 1 (p=0.013- 
0.009), 2 (p= 0.032-0.038), and 4 (p=0.03-<0.001). Number of intromissions were higher 
in trial 3 in the higher dosage group (p=0.017-0.022 ) and in trial 4 in the lower dosage 
group (p=0.019) compared to saline controls. Ethanol extract of NA ginseng improved 
the copulation efficiency in both low and high dosage groups compared to saline controls 
in trials 1 (p=0.041-0,029), 2 (p=0.013-0.01) and 4 (p=0.048-0.005). Finally, inter­
intromission interval was shorter in both lower and higher dosage groups compared to 
saline, but only in trial 1 (p=0.016-0.005) (Table 2.1). In contrast to the effects observed 
following chronic administration of the ethanol extract, the aqueous extract of NA 
ginseng did not affect male sexual behavior. No significant effects of treatment were 
detected for any of the parameters analyzed (Figure 2.1 and Table 2.1). Thus, ethanol, but 
not aqueous, extract of NA ginseng improved copulation efficiency by decreasing 
number of mounts and increasing number of intromissions.
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2.3.2. Non Contact Erections
Chronic administration of ethanol or aqueous extracts of NA ginseng did not 
affect erectile function as analyzed in the NCE test as there were no changes in the total 
number of erections or the timing to the first erection compared to control (Table 2.2).
2.3.3. Other behavioral tests
The rewarding or aversive properties of NA ginseng were tested with the CPP 
paradigm. Ethanol extract had rewarding properties as male rats displayed an increased 
preference during the post-test for the chamber of the CPP apparatus that was paired with 
the higher dose of NA ginseng ethanol extract as indicated by a increased preference 
score (p=0.009) and decreased difference score (p=0.005) (Figure 2.2A,B). The aqueous 
extract did not affect CPP parameters, hence did not have rewarding nor aversive 
properties (Figure 2.2C,D).
To determine if chronic NA ginseng administration affects general levels of 
anxiety, animals were tested for anxiety-like behavior using EPM and open field tests. 
Neither ethanol nor aqueous extracts of NA ginseng affected EPM parameters (Table 
2.3). Similar results were observed in the open field test and neither ethanol nor aqueous 
extracts affected distance moved or time spent in the center of the open field. The higher 
dose of ethanol extract did, however, increase active time in the perimeter of the chamber
compared to control (p<0.05), suggesting an effect on locomotor activity, rather than 
anxiety-like behavior (Table 2.4).
2.3.4. Penile eNOS and nNOS mRNA
Administration of ethanol extract of NA ginseng resulted in increased eNOS 
(Figure 2.3A) and nNOS (Figure 2.3B) mRNA expression in penile tissue. There was no 
effect of chronic treatment, but rather of the last injection the animals received prior to 
tissue collection (F(l, 20)=6.898; p=0.018). Hence, a final administration ofNA ginseng 
in males chronically treated with NA ginseng or saline caused increased eNOS and nNOS 
mRNA compared to saline controls.
2.3.5. Brain nNOS expression
In the PVN, ethanol extract of NA ginseng increased nNOS immunoreactivity 
(Figure 2.4). Similar to the effects observed in penile tissue, there was no effect of 
chronic administration but rather of the final injection of NA ginseng prior to tissue 
collection (F(l,19)= 5.448; p=0.033). NA ginseng significantly increased nNOS 



































Figure 2.1. Effects of ethanol (A,B,C) and aqueous (D,E,F) extracts of NA ginseng on 
number of mounts (A,D), number of intromissions (B,E), and copulation efficiency 
(mounts/intromission) (C,F). Behavior was examined 30 minutes (tests 1 and 3) or 24 
hours (tests 2 and 4) after last NA ginseng or vehicle injection. Number of animals per 
group: Ethanol extract: control: n = 19, 125 mg/kg: n = 18, 250 mg/kg: n = 19; Aqueous 
extract test 1 and 2: control: n = 18, 125 mg/kg: n = 7, 250 mg/kg: n = 18; Aqueous 
extract test 3 and 4: control: n = 9, 250 mg/kg: n = 9. Data are presented as mean ± SEM.
* indicates significance from control within each test.
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Table 2.1. Effects of ethanol and aqueous extracts of NA ginseng on latencies to mount 
(ML), intromit (IL), or ejaculate (EL), post-ejaculatory interval (PEI), and inter­
intromission interval (I IM I). All data are expressed in seconds. Behavior was examined 
30 minutes (test 1 and 3) or 24 hours (test 2 and 4) after last NA ginseng or vehicle 
injection. Number of animals per group: Ethanol extract: control: n = 19, 125 mg/kg: n = 
18, 250 mg/kg: n = 19; Aqueous extract test 1 and 2: control: n = 18, 125 mg/kg: n = 7, 
250 mg/kg: n = 18; Aqueous extract test 3 and 4: control: n = 9, 250 mg/kg: n = 9. Data 
are presented as mean ± SEM. * indicates significance from control within each test.
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Test
Ethanol 1 2 3 4
Control ML 157.1 ±48.8 67.2 ±21.9 38.1 ±11.0 21.8 ±2 .9
IL 158.9 ±48.7 78.4 ± 22.2 39.5 ± 10.9 26.2 ±3 .9
EL 412.9 ±79.7 529.3 ± 75.3 416.1 ±80.7 638.4 ± 113.2
PEI 342.8 ± 13.8 330.3 ± 18.2 380.1 ±30.1 392.5 ± 25.2
I IMI 40.9 ± 4.0 39.1 ±5 .8 42.2 ± 7.9 34.9 ±3.7
125 mg/kg ML 172.6 ±48.8 108.2 ±21.9 39.2 ±21.5 65.2 ± 2 .9
IL 179.3 ±48.7 122.2 ±45.9 45.1 ±21.6 66.1 ±39.1
EL 349.9 ±45.1 469.1 ±73.5 305.3 ±45.1 360.2 ±53.4
PEI 280.1 ±20.1 302.3 ± 14.2 328.8 ± 12.3 331.8 ± 15.5
I IMI 34.1 ±3.3* 41.5 ± 7 .0 28.3 ±3.1 32.4 ±3.1
250 mg/kg ML 68.0 ± 13.6 99.3 ± 47.4 22.1 ±4 .2 25.2 ± 5 .4
IL 75.6 ± 15.1 123.2 ±50.5 23.8 ±5.3 29.4 ±5.5
EL 357.9 ±52.2 475.8 ± 72.8 627.4 ± 145.0 349.7 ± 45.4
PEI 296.5 ± 13.8 324.7 ± 18.2 380.8 ±30.1 372.6 ±25.2
I IMI 34.8 ±4.0* 33.5 ±5.8 34.2 ± 7.9 23.6 ±3 .7
Aqueous
Control ML 98.6 ±28.3 93.4 ±43.7 210.5 ± 149.1 182.6 ±42.8
IL 101.9 ± 28.8 93.4 ±43.7 218.3 ± 148.2 183.1 ±42.9
EL 467.5 ±58.1 480.1 ±69.1 300.2 ± 46.4 497.1 ± 129.7
PEI 308.2 ± 16.3 367.2 ±47.9 326.6 ± 16.6 404.0 ± 78.7
I IMI 39.4 ± 4.9 37.8 ±5 .9 28.3 ±3.1 42.1 ±5.2
125 mg/kg ML 52.7 ±23.7 15.1 ±4 .9
IL 56.3 ± 23.4 20.7 ± 6.3
EL 372.4 ±50.9 524.7 ± 113.8
PEI 309.7 ±5 .9 304.9 ± 22.4
I IMI 33.5 ±3.1 27.8 ± 11.8
250 mg/kg ML 156.4 ±39.4 163.4 ±72.9 43.3 ± 15.8 52.3 ± 14.9
IL 234.8 ± 59.4 202.9 ± 73.0 43.7 ± 15.7 74.6 ±23.4
EL 478.7 ± 60.5 553.9 ± 160.6 389.6 ±94.7 395.8 ±90.4
PEI 356.3 ± 20.2 334.1 ± 19.7 343.4 ± 19.8 399.0 ±26.6
I IMI 43.5 ±4 .9 49.0 ± 10.2 27.6 ±4 .6 30.1 ±3 .9
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Table 2.2. Effects of ethanol extract of NA ginseng on number of non-contact erections 
(NCE) and timing to first NCE over a test period of 20 minutes. Number of animals per 
group: control: n = 20, 125 mg/kg n = 19, 250 mg/kg n = 20. Data are presented as mean 
± SEM. No significant differences between groups were detected.
Ethanol Aqueous
Number of Time to First Number of Time to First
Erections______Erection (secs) Erections______ Erection (secs)
Control 1.20 ±0.30 713.1 ±82.1 1.63 ±0.42 584.1 ±76.31
125 mg/kg 1.74 ±0.31 571.5 ±62.6 1.38 ±0.50 732.2 ± 136.4
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Figure 2.2. Conditioned Place Preference (CPP) data for two doses of ethanol (A,B) or 
aqueous (C,D) extracts of NA ginseng. Animals received NA ginseng approximately 24 
hours prior to testing. Data are presented as a preference score (A,C; percentage of time 
spent in paired chamber as a ratio of paired and unpaired chambers) and difference score 
(B,D; time spent in paired minus unpaired chamber) during the pre- (white bars) and 
post-test (black bars). Numbers of animals per group: Ethanol extract: control: n = 20,
125 mg/kg: n = 19, 250 mg/kg: n = 21; Aqueous extract: control: n = 9, 125 mg/kg: n = 8, 




Table 2.3. Effects of chronic administration of ethanol and aqueous extracts of NA 
ginseng on behavior in the elevated plus maze (EPM). Data are presented as mean ± SEM 
of the percent of time spent in open or closed arms and the number of entries into the 
open or closed arms of the EPM apparatus during a five minute test period. Numbers of 
animals per group: Ethanol extract: control: n = 19, 125 mg/kg: n = 18, 250 mg/kg: n = 
21; Aqueous extract: control: n = 9, 125 mg/kg: n = 8, 250 mg/kg: n = 7. No significant 
differences between groups were detected.
Percent of Time # of Entries





28.17 ± 1.56 
27.97 ±2.14
64.66 ± 3.50 
61.44 ± 1.78
59.66 ± 2.64













61.13 ± 7.71 
52.61 ±4.11
5.33 ± 1.30 
4.63 ± 1.10 
7.29 ± 1.02




Table 2.4. Effects of chronic administration of ethanol and aqueous extracts ofNA 
ginseng on behavior in an open field test. Data are presented as mean ± SEM of the 
ambulatory distance and the time the animal was active in the center and perimeter of the 
apparatus during a twenty minute testing period. Numbers of animals per group: Ethanol 
extract: control: n = 20, 125 mg/kg: n = 19, 250 mg/kg: n = 22; Aqueous extract: control: 
n = 9, 125 mg/kg: n = 8, 250 mg/kg: n = 7. * indicates significance from control.
Ambulatory Distance (cm) Active Time (secs)







2355 ± 140 
2243 ± 164 
2671 ±97
115.6 ± 14.9 









280.0 ± 40.2 
367.6 ±60.3






1106 ± 114.9 
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Figure 2.3. Effects of ethanol extract of NA ginseng on mRNA expression of eNOS (A) 
and nNOS (B) in penile tissue. Males were treated chronically with saline or NA ginseng 
(250 mg/kg) and received vehicle or NA ginseng (250 mg/kg) 1 hour prior to tissue 
collection, n = 5 (groups: saline/saline, ginseng/saline, saline/ginseng) or n=6 
(ginseng/ginseng group). Data are presented as mean ± SEM. * indicates significant 
difference between groups last treated with NA ginseng compared to saline.
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Figure 2.4. Effects of ethanol extract of NA ginseng on nNOS immunoreactivity in the 
paraventricular nucleus of the hypothalamus (PVN). A is a schematic drawing of area of 
analysis (Paxinos and Watson, 1998); 3V: third vetricle; fx: fomix; ot: optic tract. B 
illustrates the quantitative densitometry analysis showing percentage of the area of 
analysis that is above threshold in males chronically treated with saline or NA ginseng 
(250 mg/kg) and received vehicle or NA ginseng (250 mg/kg) 1 hour prior to tissue 
collection, n = 5 for all groups. Data are presented as mean ± SEM. * indicates significant 
difference between groups last treated with NA ginseng compared to saline. C and D 
show representative images of nNos immunoreactivity in the PVN of males treated with





The results of this study show that administration of NA ginseng results in 
facilitation of sexual behavior in adult, male rats. In particular, ethanol extract of NA 
ginseng improved copulation efficiency, which is indicative of improved erectile function 
(Clark, 1995). These effects on erectile function were only noted when animals were 
tested in a mating context and were not observed when males were not in direct contact 
with an estrus females. NA ginseng ethanol extract may modulate erectile function by 
increasing expression of nNOS and eNOS in erectile tissues and nNOS in the PVN; 
however other unknown pathways are involved.
The effects of ginseng on male sexual behavior have been reported in rats (Kim et 
al., 1976; Murphy et al., 1998; Wang et al., 2010b), mice (Yoshimura et al., 1998), 
rabbits (Chen and Lee, 1995; Choi et al., 1999) and humans (Hong et al., 2002; de 
Andrade et al., 2007; Jang et al., 2008; Kim et al., 2009). The majority of these studies 
were conducted using extracts of Asian ginseng or its processed form known as Korean 
Red ginseng, which is the steamed root of Asian ginseng. Human studies have shown 
improved male erectile ability as indicated by physiological tests on penile rigidity and 
self-reporting scores on penetration, erection maintenance, and rigidity using the 
International Index of Erectile Function (IIEF) (Hong et al., 2002; de Andrade et al., 
2007; Jang et al., 2008; Kim et al., 2009). The animal studies on ginseng have shown a 
propensity to induce vasodilation in erectile tissue that will cause an erection and 
improve male sexual performance (Kim et al., 1976; Choi et al., 1999). Other studies 
have used ginsenoside extracts, rather than full root extracts, to test the effects on sexual
behavior (Yoshimura et al., 1998; Wang et al., 2010b). Ginsenosides are considered the 
main active constituents of the ginseng genus (Leung and Wong, 2010; Wang et al., 
2010a; Tsutsumi et al., 2011; Yin et al., 2011). Previous studies have identified Rgl as a 
main contributor to enhancing male sexual behavior with little to no contribution from 
ginsenosides Rbl or Rb2 (Yoshimura et al., 1998; Wang et al., 2010b). Much less is 
known about the effects of other ginseng species, such as NA ginseng, on male sexual 
behavior. The only previous study on male sexual behavior with NA ginseng 
demonstrated an increase in sexual performance indicated by decreased latencies to 
mount, intromission, and ejaculation (Murphy et al., 1998). The current study did not 
demonstrate effects of NA ginseng on measures of motivation. Rather, it was shown that 
NA ginseng facilitates male sexual behavior by improving copulation efficiency and 
reducing number of mounts prior to ejaculation. These parameters reflect erectile 
function (Clark, 1995). Hence, NA ginseng improved erectile function during mating. 
Moreover, the effect of NA ginseng was evident in males that were sexually naive or 
experienced.
The effects of NA ginseng appeared dependent on the context in which erectile 
function was observed; i.e. it was improved during mating behavior but effects of NA 
ginseng were not detected on NCE. NCE are considered a representation for erectile 
function induced by arousal, which are called psychogenic erections in humans (Sachs 
and Garinello, 1978). Potential explanations for the difference in facilitation of erection 
include dosage of NA ginseng; effects with NCE may require higher dosages. In addition, 
the lack of effects of NA ginseng on NCE may be related to differences in neural control
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of erections during mating compared to NCE. For example, lesions of the medial preoptic 
area (mPOA) caused a large impairment in sexual performance during mating but had 
minimal to no effects on NCE (Liu et ah, 1997a). The mPOA is essential for 
orchestrating male sexual behavior and studies have shown its activation during sexual 
behavior (Coolen et ah, 1996, 1998). In the same study mentioned above, Liu and 
colleagues reported the reverse effect in the bed nucleus of the stria terminalis (BNST); 
lesions mostly abolished NCE but had little effect on copulatory performance. The BNST 
is a conduit for information between brain regions involved in male sexual behaviour and 
is activated during appetitive and consummatory phases of copulation (Kondo and Arai, 
1995; Coolen et ah, 1997). Consequently, NA ginseng may not affect the neural 
substrates mediating NCE.
An objective of the current study was to differentiate any erectile enhancing 
effects between two common extracts of ginseng: ethanol and aqueous, since different 
effects of extract preparations have been reported on immunomodulation and the 
cardiovascular system (Lee et ah, 1981; Azike et ah, 2011). Indeed, differing effects of 
the two extracts were noted; improved erectile function occurred only with the 
administration of ethanol extract and not with the aqueous extract of NA ginseng. Both 
extracts have different ginsenoside profiles based on the solubility of the individual 
ginsenosides (Azike et ah, 2011). The ethanol extract of the NA ginseng used in the 
current study has a higher percentage of ginsenoside content (approximately 28% total 
ginsenoside content by weight in ethanol extract compared to 14% in aqueous extract). 
While ginsenoside Rbl has been shown not to have an effect on preventing male mice
copulatory disorder when testing the latencies and frequencies of sexual behavior 
parameters (Yoshimura et al., 1998), its ability on enhancing erectile function has not 
been examined and cannot be ruled out in our study. Ginsenoside Rgl has been shown to 
enhance sexual behavior (Yoshimura et al., 1998; Wang et al., 2010b); however, Rgl 
concentrations did not significantly differ between extracts. As such, ginsenoside Rgl is 
unlikely to account for differences in erectile enhancing effects seen between extracts. 
Moreover, differences in extract effectiveness may be due to a minimum effective dose; 
ginsenoside concentration in the aqueous extract may not be sufficient to induce an 
effect. More studies are needed to determine which ginsenosides of NA ginseng are 
active at improving erectile function. Finally, differences in extract effects may also be 
due to polysaccharides (PS), which are found in NA ginseng. Although ginsenosides have 
traditionally been seen as the principal active constituents of ginseng, studies show that 
PS have active properties and are found in aqueous, not ethanol, extracts (Azike et al., 
2011). However, since aqueous extract was not effective in facilitating erectile function, 
it is unlikely that PS are major contributors to the effects of ginseng on male sex function.
The mechanisms by which NA ginseng influences sexual behavior are unclear. It 
has been proposed that ginseng affects the cellular mediators of erectile function in the 
erectile tissues and/or testosterone synthesis (Chen and Lee, 1995; Choi et al., 1999; 
Wang et al., 2010b). Ginseng extracts cause vasodilation in the vasculature as shown in 
in vivo (Tsutsumi et al., 2011; Xu et al., 2011) and in vitro (Kang et al., 1995; Toda et 
al., 2001; Tsutsumi et al., 2011) studies. Effects of ginseng on cellular mediators of 
erectile function (Gratzke et al., 2010) have also been demonstrated. Concentration-
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dependent vasodilatory effects of Asian ginseng in vitro using rabbit corpus cavemosum 
(Chen and Lee, 1995) have been reported in addition to increased levels of cGMP in 
ginseng-treated tissue. Chen and Lee acutely treated penile tissue with ginseng for 10 
minutes and discovered an increase in the percent relaxation compared to control. Also, 
ginseng has been shown to act at the vascular level on the NO/cGMP pathway to induce 
erections. Chronic administration of Rgl ginsenoside extract increased cGMP and NO 
levels in mice corpus cavemosum concomitant to improved sexual performance (Wang et 
al., 2010b). The current study provides a potential target of an upstream effect of ethanol 
extract of NA ginseng on the NO/cGMP pathway. NA ginseng ethanol extract increased 
levels of both eNOS and nNOS in penile tissue. Unexpectedly, levels of nNOS and eNOS 
mRNA were not up-regulated by chronic, but rather by acute administration of ethanol 
extract. Previous studies have shown minute concentrations of ginsenosides in circulation 
within 15 minutes after oral administration (Song et al., 2010). Furthermore, ginseng 
extracts have been demonstrated to induce NO-mediated relaxation of rabbit corpus 
cavemosum and increased cGMP levels after only 10 minutes of exposure (Chen and 
Lee, 1995). Hence, it is possible that NA ginseng increases eNOS and nNOS mRNA in 
the corpus cavemosum one hour after injection, which can lead to an increase in cGMP 
content in smooth muscle cells. However, the increase in nNOS and eNOS mRNA does 
not appear to be required for the facilitative effects of NA ginseng on erectile function, as 
chronic administration of ginseng altered sexual function without altering mRNA levels 
for nNOS or eNOS in penile tissue.
Another potential mediator of the effects of ginseng on sexual function is the 
steroid hormone testosterone. Chronic ginsenoside Rgl exposure has been shown to 
result in increased levels of testosterone in plasma of male mice (Wang et al., 2010b). In 
contrast, another study using NA ginseng detected no effects on testosterone levels 
(Murphy et al., 1998). As such, further studies are needed to determine if NA ginseng has 
any effect on hormone levels in animals and in humans.
Ginseng may influence sexual function by acting on the brain. Hence, the current 
study tested if ethanol extract of NA ginseng influenced brain areas that mediate erectile 
function such as the PVN (McKenna, 2000). The PVN is an integration center involved 
in many autonomic processes (Argiolas and Melis, 2005). The role of the PVN in male 
erectile function has been well established through studies showing stimulation induces 
penile erection (Melis et al., 1994; Chen and Chang, 2002, 2003) and bilateral lesions 
greatly reduces the ability to obtain an erection (Argiolas et al., 1987; Liu et al., 1997b). 
A role for oxytocinergic neurons in the PVN in the control of penile erection in the male 
rat has been implicated (Argiolas and Melis, 2004). In turn, PVN oxytocin neurons are 
influenced by endogenous NO production by nNOS to cause release of oxytocin in extra- 
hypothalamic brain regions and the spinal cord (Melis et al., 1996; Melis and Argiolas, 
1997; Melis et al., 1997).
The current study demonstrated an increase in nNOS immunoreactivity in the 
PVN of rats treated with ethanol extract of NA ginseng one hour before sacrifice.
Chronic administration did not influence nNOS immunoreactivity. Similar to the penile
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tissue, the increase in nNOS in the PVN does not appear to be required for the facilitative 
effects of NA ginseng on male sexual behavior. These data suggest that NA ginseng may 
influence erectile function via increased nNOS expression; in turn possibly activating 
oxytocin projections from the PVN. However, chronic administration of NA ginseng 
enhanced sexual behavior during copulation, however, did not influence nNOS in the 
PVN. As such, alternate mechanisms of action exist for the ethanol extract of NA ginseng 
to enhance erectile function besides those detected in the current experiment.
Finally, the current study shows that ethanol extract of NA ginseng has rewarding 
properties since males formed a conditioned place preference, a widely used test for 
reward-seeking behavior (Tzschentke, 2007). Also, ginseng has also been indicated to be 
anxiolytic (Carr et al., 2006). In the previous study, anxiety behaviors were tested 
immediately following Asian ginseng administration at high dosing levels; however, the 
current study tested animals after approximately 24 hours after last injection and used 
lower doses of NA ginseng. As such, the lack of anxiolytic effects of our study may be 
due to timing of injection prior to testing and the doses used. Indeed, studies have shown 
that chronic Asian ginseng administration at doses similar to those used in our 
experiment do not have anxiolytic properties (Einat, 2007). Therefore, anxiolytic effects 
of ginseng may only be detected shortly after consumption and may not be long lasting.
In conclusion, this study shows that ethanol, but not aqueous, extract of NA 
ginseng increased erectile function in male rats during mating behavior. NA ginseng 
effects are potentially mediated through eNOS and nNOS mRNA in penile tissue and
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nNOS density in the PVN; however, other mechanisms of action contribute to its pro- 
erectile effects seen during chronic treatment, which are yet to be discovered.
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Chapter 3: North American ginseng improves erectile function in Obese Zucker
rats.
3.1. Introduction
Erectile dysfunction (ED) is a serious disorder that decreases the quality of life in 
men and their partners (Vickers and Wright, 2004). ED may occur by various alterations 
in physiology. It has been well established that nitric oxide (NO) is the main cellular 
mediator of erectile function, causing vasodilation in the corpus cavemosum in penile 
tissue (Awad et al., 2011). Type 2 Diabetes Mellitus (T2DM) patients experience many 
physiological alterations that predispose them to ED such as decreased neuronal nitric 
oxide synthase (nNOS) expression (Xie et al., 2007) and increased reactive oxygen 
species (ROS) that scavenge for NO in vasculature and decrease its availability to 
vasodilate corpus cavemosum (De Young et al., 2004; Yan et a l, 2008). While under 
10% of the general male population experiences some form or ED, men with T2DM have 
a prevalence rate of approximately 28% (Feldman et al., 1994). In addition, only 56% of 
men with T2DM respond to phosphodiesterase type 5(PDE5) inhibitors as compared to 
87% of the general population (Rendell et al., 1999). Moreover, men who responded 
positively to PDE5 inhibitors may revert back to pre-treatment conditions (Penson et a l, 
2003). Hence, development of additional pharmacological treatments is needed.
In the current study, North American (NA) ginseng was examined as a potential 
treatment for ED. The two most common species in the ginseng genus are Panax ginseng
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(Asian ginseng) and Panax quinquefolius (North American ginseng). Extracts of Asian 
ginseng and Korean Red ginseng, created when Asian ginseng is steamed, have been 
shown to facilitate male sexual behavior (Yoshimura et al., 1998; Choi et al., 1999; Hong 
et al., 2002; de Andrade et al., 2007; Kim et al., 2009) and to cause vasodilation in 
corpus cavemosum (Chen and Lee, 1995; Kang et al., 2005). In addition, NA ginseng has 
been shown to enhance erectile function and sexual performance in male rats (Murphy et 
al., 1998; Barnes et al., 2011).
Ginsenosides are triterpenoid glycosides, also called saponins, and are considered 
the principal active constituents in ginseng (Attele et al., 1999; Leung and Wong, 2010). 
Ginsenosides have been shown to reduce glucose levels in blood (Ji and Gong, 2007) and 
increase glutathione and decrease markers of lipid peroxidation (Ryu et al., 2005). Hence, 
NA ginseng may restore some of the underlying physical alterations associated with 
T2DM that contribute to ED development.
The current study tested if NA ginseng improves erectile function using Obese 
Zucker (OZ) rats as a pre-diabetic model for T2DM, as T2DM accounts for 90-95% of 
diabetic patients (Hidalgo-Tamola and Chitaley, 2009). OZ rats have an autosomal 
recessive mutation in the leptin receptor gene (Kasiske et al., 1992), and represent a less 
severe model of ED caused by diabetic complications than a model with complete 
diabetes such as the Zucker Diabetic rat (Garcia et al., 2009). Also, similar to T2DM 
patients, OZ rats have hyperinsulinemia, insulin resistance, glucose intolerance, 
hyperlipidemia, obesity, hypertension, and impaired vasodilation (Kasiske et al., 1992).
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This study examines the effects of NA ginseng on mating behavior, penile reflexes, and 
cellular mediators of erectile function in penile tissue of OZ rats.
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3.2. Methods and Materials
3.2.1. Animals
Adult male OZ (250-300 g) and Lean Zucker (LZ) (200-250 g) rats were obtained 
from Charles River (Sherbrooke, Quebec, Canada). Rats were housed in pairs in standard 
Plexiglas holding cages, under a 12/12 light-dark cycle (lights off at 10 a.m.) with food 
and water available at all times. Female Long Evans rats (200-225 g; Charles River) were 
bilaterally ovariectomized and subcutaneously implanted with a capsule containing 5% 
17-P-estradiol benzoate (Sigma, St. Louis, Missouri, USA) and 95% cholesterol (Sigma, 
St. Louis, Missouri, USA). Sexual receptivity in females was induced on test days with a 
subcutaneous injection of 500 mg progesterone dissolved in 0.1 mL sesame oil (Sigma, 
St. Louis, Missouri, USA) four hours prior to experiments. All procedures were approved 
by the Animal Care Committee at the University of Western Ontario and conform to the 
guidelines of the Canadian Council on Animal Care (Ottawa, Ontario, Canada).
3.2.2. North American Ginseng Extracts and Administration
Roots of NA ginseng from five farms in Ontario, Canada were harvested after 
four years of growth by the Ontario Ginseng Grower’s Association. Roots were 
processed by Naturex (South Hackensack, New Jersey) by grinding and soaking them at 
40°C, three times for a total of five hours in either 75% ethanol or aqueous solutions. The 
ethanol or aqueous extracts were filtered and heated at 45 °C to remove excess solvent to
produce 60% total solid content. Ethanol and aqueous NA ginseng root extracts were 
prepared after lyophilization at the Ontario Ginseng Innovation and Research Consortium 
(University of Western Ontario, London, Canada). Concentration for the major 
ginsenosides (Rbl Re, Rgl, Rb2, Rd, and Rc) in both extracts have previously been 
determined by high-pressure liquid chromatography (Azike et al., 2011).
Saline (0.9%) was used to suspend the powdered NA ginseng ethanol or aqueous 
extracts and rats were injected daily with either extract (250 mg/kg) or vehicle (saline) 
via oral gavage two to three hours after lights off under red light illumination unless 
otherwise stated for test days. Concentration of each injection was adjusted based on the 
weights of the animals so all injection volumes were less than 1 mL per day.
3.2.3. Experimental design
In the first experiment, untreated OZ and LZ rats (n = 10) were tested for sexual 
behavior every other day for three tests. In the second experiment, a separate group of OZ 
rats were treated with ethanol or aqueous NA ginseng extracts or vehicle (n = 12 for 
saline and aqueous groups, n = 13 for ethanol group) and tested for sexual behavior in a 
series of four tests every other day after 28 days of daily NA ginseng or vehicle 
administration. Subsequently, these males were tested for erectile function using ex 
copula tests. Throughout the experiment, males were weighed every two days prior to 
injection. Average weight of treatment groups did not differ at the start of the experiment. 
For each animal body weights were expressed as a percentage of the initial body weight 
at start of the experiment. Differences between groups were analyzed using repeated
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measures ANOVA (factors: time and treatment) and Student-Newman-Keuls for post hoc 
analyses with 95% confidence levels (SigmaPlot version 11.0).
3.2.4. Sex Behavior
Tests occurred every other day for a total of three (untreated OZ and LZ rats; 
experiment 1) or four (treated OZ rats; experiment 2) tests. Male rats were sexually naive 
prior to the start of the tests. As such, effects of treatment on sexual behavior were 
determined in the rats while naive and sexually experienced. In experiment 2, at the start 
of the experiment, weights of the groups were measured for appropriate dosing. In 
addition effects of NA ginseng treatment were tested either 30 minutes or 24 hours 
following last drug administration; for tests 1 and 3 rats received NA ginseng 30 minutes 
prior to mating while during tests 2 and 4 rats received NA ginseng 24 hours prior to 
testing. As such, testing examined acute and chronic effects of NA ginseng dosing. 
During all tests, rats were placed in a clean test cage (60 x 45 x 50 cm3) ten minutes prior 
to introduction of a receptive female. Male rats were allowed to mate to either one 
ejaculation (and completed post-ejaculatory interval; PEI) or for one hour, whichever 
came first. All standard parameters of male sexual performance were recorded including: 
mount latency (ML; time from introduction of receptive female until the first mount), 
intromission latency (IL; time from introduction of receptive female until the first mount 
with successful vaginal penetration), ejaculation latency (EL; time from the first 
intromission until ejaculation), PEI (time from ejaculation to first subsequent 
intromission), numbers of mounts and intromissions (M and IM) prior to ejaculation,
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copulation efficiency (CE; ratio of number of intromissions to total number of mounts 
plus intromissions), and inter-intromission interval (I IM I; testing period divided by 
number of intromission). Because few OZ rats ejaculated within one hour, all animals 
were included in the analysis if they performed at least one mount (approximately 50% in 
naive rats and up to 90% by final test); no values for latencies were recorded unless the 
rat performed the particular sex behavior parameter. In addition, when calculating I IM I, 
if the rat intromitted but did not ejaculate then a value of 3600 seconds for EL was used 
(duration of test). For both experiments, differences between groups were compared 
using two-way analysis of variance (factors: trial and strain (LZ vs. OZ) or treatment (NA 
ginseng vs. vehicle)) and all pairwise multiple comparison procedures with Holm-Sidak 
method for post hoc analysis with 95% confidence levels.
3.2.5. Ex Copula Tests
A testing apparatus consisting of a Plexiglas base fixed to a 12 inch tube was used 
to restrain the rats in a supine position with the rat’s head and upper torso inside the tube 
and lower torso and legs exposed. Rats were habituated to the apparatus and testing 
position for 10 minutes for four consecutive days prior to testing. On test days, the penile 
prepuce was retracted to allow measurements of penile reflexes (Sachs and Garinello, 
1978) and rats were video recorded for 30 minutes if no erection occurred or for 15 
minutes after the first erection. Rats received NA ginseng or saline 30 minutes prior to 
testing. Videos were scored by an experimenter blinded to treatment groups and the 
following measures were quantified: El erections (base of glans engorges with blood),
E2 erections (both tip and base of glans engorge with blood), E3 erections (cups; an E2 
erection with flaring of the tip of the glans so that the diameter of the glans tip surpassed 
the base), FI anteroflexions (ventral penile extension from resting position that is less 
than 90 degrees from ventrum), and F2 anteroflexions (ventral penile extension from 
resting position that surpasses 90 degrees from ventrum) (Sachs, 1985). Also, the latency 
to the first erection and clusters of erections within 30 seconds (series of penile responses 
occurring within a 30 second time period) were recorded (Sachs, 1985). Differences 
between either the ethanol or aqueous group and control vehicle-treated group were 
compared using Mann-Whitney Rank Sum tests with 95% confidence levels. Percentages 
of animals displaying E3 erections were compared between groups using Chi-square 
analysis.
3.2.6. Tissue Collection
Following completion of behavioral tests, animals received an overdose of 
pentobarbital (270 mg/mL/kg) and blood, testes, and penile tissues were harvested. In 
experiment 1, LZ and OZ rats were not treated prior to tissue collection. In experiment 2, 
rats chronically treated with NA ginseng were administered either a final dose of NA 
ginseng or vehicle one hour before sacrifice, thus, five treatment groups were created to 
determine the effects of NA ginseng on cellular mediators of erectile function. Testes 
were weighed at time of collection. Penile tissues were frozen at -80°C until processing 
for real time PCR. Blood was collected in centrifuge tubes containing heparin 
(Pharmaceutical Partners of Canada Inc., Richmond Hill, ON, Canada) and centrifuged at
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3000 rpm for 15min at 0°C (Beckman Model TJ-6 centrifuge attached to a TJ-R 
Refrigeration Unit). Plasma was removed, aliquoted and stored at -80°C until further 
processing for steroid assays.
3.2.7. Real time PCR
Penile tissues of untreated LZ and OZ, and NA ginseng or vehicle treated OZ males 
were homogenized in TriZol reagent (Invitrogen, Burlington, ON) for total RNA 
isolation. RNA quantity and purity were assessed using a NanoDrop spectrophotometer 
(ND 1000 v3.3.0; NanoDrop Technologies, Inc., Wilmington, DE) to ensure that the 
260/280nm absorbance ratio was between 1.8 and 2.0. cDNA synthesis was performed 
using the High Capacity cDNA Reverse Transcription Kit (Applied Biosystems Inc., 
Foster City, CA) according to the manufacturer’s instructions. Following cDNA 
synthesis, nNOS and eNOS gene expression was quantified by qRT-PCR. Each reaction 
contained 2pL of cDNA, lOpL of TaqMan Universal PCR Master Mix 2X (Applied 
Biosystems), 0.8pL of 25mM MgCl2  (Invitrogen), 6.2pL DEPC treated water, and lpL of 
TaqMan gene expression assay solution for the gene of interest (nNOS Assay ID: 
Rn00583793_ml; eNOS Assay ID: Rn02132634_sl). Glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH) (Assay ID: Rn99999916_sl) was used as an endogenous 
control. Each sample was assayed in triplicate using the Rotor Gene RG 6000 
thermocycler and software (Corbett Life Sciences, San Francisco, CA) at the following 
cycling conditions: hold at 50°C for 2 min and 95°C for 10 min, 40 cycles of 95°C for 15 
sec and 58°C for 1 min. Quantification of gene expression was calculated by use of a
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standard curve generated from qRT-PCR for each gene analyzed. cDNA reverse 
transcribed from RNA isolated from penile tissue was used to create a standard curve 
with 5-log serial dilutions. Standard curves were deemed optimal when the line of best fit 
through the cycle threshold (Ct) values of the dilutions had a R > 0.99 and an efficiency 
value between 0.8-1. An optimal threshold line generated from the standard curve for 
each gene was used to determine the Ct value for each sample. The Ct of each experiment 
sample was determined from the intersection between the baseline subtracted 
amplification curve of the sample and the threshold line established by the optimal 
standard curve. For each experiment sample, the Ct value for each gene of interest was 
normalized to their respective Ct value of the housekeeping gene, GAPDH. This value 
corresponds to the ACt value. Furthermore, the difference between the ACt value for each 
individual sample in the treatment groups and the average ACt value of the control group 
was calculated as the AACt value (= 2 A(A C t(Sampie) - AQaverage))* 100). One-way ANOVA 
with Holms Sidak post hoc analysis were conducted to identify significant differences 
between groups. Values were considered significantly different with/?<0.05.
Testosterone Analysis
All samples were assayed at the Core Assay Facility in the Department of 
Psychology at the University of Michigan (Ann Arbor, Michigan). ELISA kits 
specifically designed for measuring testosterone in mouse/rat serum or plasma were used 
(Cat. # TE187S-100, Calbiotech Inc, USA). The reference for this ELISA ranged from
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0.1-18.0 ng/mL and 25 uL of standards, samples, and controls were analyzed in duplicate. 




Sexual behavior was severely impaired in OZ rats compared to LZ controls 
(Figure 3.1). Effects of strain (LZ vs. OZ) were detected for latencies to mount (F 
(1,52)=5.86; p=0.019) and intromit (F (1,54)=5.55; p=0.023), numbers of mounts (F 
(1,54)= 38.95; p=<0.001) and intromissions (F (1,54)=41.65; p=<0.001), copulation 
efficiency (F (1,52)=159.56; p=<0.001) and inter-intromission intervals (F (1,49)=56.09; 
p=<0.001). Impaired behavior was detected during all three trials, indicating that sexual 
experience did not alleviate the impairments. One of the OZ males reached ejaculation 
during any of the three tests compared to 100% of LZ rats.
NA ginseng improved sexual behavior in OZ males. Treatment effects were 
detected on copulation efficiency (F (2,106)=8.8; p=<0.001) and numbers of intromission 
(F (2,108)=4.1; p=0.020). Post hoc analyses revealed facilitative effects of aqueous 
extract during test 3 and test 4, the latter with a strong trend (p = 0.062 ), and ethanol 
extract during tests 1 and 4 (Figure 3.2). Hence, both extracts improved copulation 
efficiency on test days. In addition, treatment effects were found on mount (F(2, 
100)=12.67; p=<0.001) and intromission (F(2, 85)=13.14; p=<0.001) latencies (Table 
3.1). Specifically, aqueous and ethanol extracts of NA ginseng significantly shortened 
mount and intromission latencies, but only during the first test when males were sexually
81
naïve. Also, aqueous extract improved intromission latency during the second test, but no 
effects during the subsequent tests were found.
3.3.2, Ex copula test
In addition to improving erectile function during mating behavior, NA ginseng 
also improved penile reflexes determined by the ex copula tests (Figure 3.3). Ethanol, 
but not aqueous, extract significantly improved total number of erections (p=0.034), and 
the percentage of animals displaying E3 erections (p=0.044), with a trend towards 
significance for the percentage of E3 erections (p=0.065). Other parameters were not 
affected by either extract (Table 3.2).
3.3.3. eNOS and nNOS mRNA
There were no significant differences in either eNOS (OZ: 119 ± 13.5 % fold 
change compared to LZ) or nNOS (OZ: 92 ± 5.7 % fold change compared to LZ) mRNA 
content in penile tissue between LZ and OZ rats. Ethanol extract of NA ginseng increased 
nNOS (F(2,15)=9.2; p=0.002) and eNOS (F(2,16)= 4.78; p=0.024) mRNA (Figure 3.4). 
Post hoc analyses demonstrated that males chronically treated with ethanol NA ginseng 
and received a final ginseng administration prior to tissue collection (EE) had increased 
nNOS (p<0.001) and eNOS (p=0.008) compared to chronic saline treated groups (SS). In 
contrast, chronically treated ethanol NA ginseng males that received saline on the final 
day (ES) had increased nNOS (p=0.015), but not eNOS. Hence, it appears that in addition
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to the chronic treatment, the final administration prior to tissue collection affected levels 
of eNOS, but not nNOS. Aqueous extract of NA ginseng did not have any effect on levels 
of nNOS or eNOS (Table 3.3).
3.3.4. Body weight
NA ginseng affected weight gain in OZ males (F(2, 816)=53.935; p<0.001); 
significantly lower increases in bodyweight compared to vehicle-treated males were first 
detected following 25 (aqueous) or 33 days (both extracts) of daily administration (Figure
3.5) .
Testes weight and Testosterone Levels
OZ rats had a decrease in testes weight compared to LZ rats (p=0.004) (Figure
3.6) . Testes weight was increased by treatment with NA ginseng (Figure 3.6) as ethanol, 
but not aqueous, extract significantly increased testes weight compared to saline-treated 
controls (p=0.041). However, plasma testosterone levels were not affected by NA 
ginseng as there were no significant differences between control (2.0 ± 0.2 ng/mL) and 











Figure 3.1. Latency to mount (A) and intromit (B), number of mounts (C), and 
intromissions (D), copulation efficiency (mounts/intromission) (E), and inter­
84
intromission interval (F) in adult, male Lean and Obese Zucker rats during three 
consecutive tests (test 1-3). Data are presented as mean ± SEM. * indicates significance 
from lean group within each test.
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Test  1 2  3 4
Time 30 Mins 24 Hrs 30 Mins 24 Hrs
Figure 3.2. Effects of ethanol and aqueous extracts of NA ginseng on copulation 
efficiency (mounts/intromission) in male Obese Zucker rats after 28 days of oral 
treatment at 250 mg/kg. Behavior was examined 30 minutes (tests 1 and 3) or 24 hours 
(tests 2 and 4) after last ginseng or vehicle injection. Number of animals per group: 
control: n = 11, aqueous: n = 12, ethanol: n = 13. Data are presented as mean ± SEM. * 
indicates significance from control within each test and # indicates p = 0.062 compared to
control.
Table 3.1. Effects of aqueous and ethanol extracts of NA ginseng on mount (ML) and 
intromission (IL) latencies (seconds), frequency of mounts (# M) and intromissions (# 
IM), and inter-intromission interval (I IM I; seconds) in sexually naive male Obese 
Zucker rats. Behavior was examined 30 minutes (tests 1 and 3) or 24 hours (tests 2 and 4) 
after last NA ginseng or vehicle injection. Number of animals per group: control: n = 11, 
aqueous: n = 12, ethanol: n = 13. Data are presented as mean ± SEM. * indicates 
significance from control within each test.
Test
1 2 3 4
Control ML 1123 ±397 415 ±112 85 ±27 34 ± 9
IL 1405 ±523 657 ±218 103 ±37 64 ±31
#M 8 ± 4 9 ± 4 34 ± 10 42 ± 10
#IM 3 ± 2 2 ± 1 7 ± 2 6 ± 2
I IM I 1288 ±645 1813 ±734 476 ± 95 967 ±355
Aqueous ML 202 ±115* 177 ±72 112 ± 80 26 ± 8
IL 405± 198* 116 ±50* 171± 138 31 ± 6
#M 9 ± 3 23 ± 9 26 ± 9 50 ± 10
#IM 5 ± 2 9 ± 3 9 ± 3 15 ± 4
I IM I 912 ±454 741 ± 413 717 ± 421 396 ± 96
Ethanol ML 200 ±56* 246 ±115 113 ± 55 32 ± 7
IL 267 ±83* 349± 137 144 ± 82 110 ± 49
#M 14 ± 5 12 ± 4 46 ±9 31 ± 8
#IM 9 ± 3 3 ± 1 9 ± 2 11 ± 4




























Figure 3.3. Effects of ethanol and 
aqueous extracts of NA ginseng on 
number of erections (A), percent of E3 
erections (B), and percent or rats 
displaying E3 erections (C) during the 
ex copula test in sexually experienced 
male Obese Zucker rats. NA ginseng or 
vehicle was administered 30 minutes 
prior to testing. Number of animals per 
group: control: n = 8, aqueous: n = 9, 
ethanol: n = 12. Data are presented as 
mean ± SEM. * indicates significance 
from control group within each test and 




Table 3.2. Effects of aqueous and ethanol extracts of NA ginseng on parameters of ex 
copula tests in sexually experienced, adult, male Obese Zucker rats. NA ginseng or 
vehicle was administered 30 minutes prior to testing. Number of animals per group: 
control: n = 8, aqueous: n = 9, ethanol: n = 12. Data are presented as mean ± SEM. No 
significant differences between groups within each test were detected.
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Control Aqueous Ethanol
Time to First Erection 333.5 ±95.8 227.2 ± 54.5 194.0 ±35.5
# Flips 2.0 ± 1.0 1.3 ±0.6 3.0 ±0.9
% F2 Flips 7.5 ±5.0 6.3 ± 6.3 32.0 ± 11.6
# Clusters 0.5 ±0.3 0.3 ± 0.2 2.0 ±0.5
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Chronic Saline Ethanol Ethanol
Last Saline Saline Ethanol
Chronic Saline Ethanol Ethanol
Last Saline Saline Ethanol
Figure 3.4. Effects of ethanol extract of NA ginseng on mRNA expression of eNOS (A) 
and nNOS (B) in penile tissue. Males were treated chronically with saline or NA ginseng 
(250 mg/kg) and received vehicle or ginseng (250 mg/kg) 1 hour prior to tissue 
collection. Number of animals per group: saline/saline: n = 7, ethanol/saline: n = 6, 
ethanol/ethanol: n = 6. Data are presented as mean ± SEM fold change compared to the 
chronic saline treated control group (white bar). * indicates significant compared to 
chronic saline-treated group.
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Table 3.3. Effects of aqueous extract of NA ginseng on penile eNOS and nNOS mRNA 
in sexually experienced, adult, male Obese Zucker rats. NA ginseng or vehicle (250 
mg/kg) was administered chronically for 50 day then rats received a final injection of 
either saline or NA ginseng 1 hour prior to sacrifice. Number of animals per group: 
saline/saline: n = 10, aqueous/saline: n = 5, aqueous/aqueous: n = 6. Data are presented as 
mean ± SEM percent change compared to the chronic saline-treated group. No significant 
differences between groups were detected.
Chronic Treatment Saline Aqueous Aqueous
Final Treatment Saline Saline Aqueous
eNOS 107 ± 14 76 ± 10 87 ± 9
nNOS 106 ± 13 107 ± 4 98 ± 14
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Day
Figure 3.5. Weight of Obese Zucker rats treated with aqueous and ethanol extracts of NA 
ginseng. Measurements were conducted one to two hours after lights off before daily NA 
ginseng administration. Number of animals per group: control: n = 12, aqueous: n = 12, 
ethanol: n = 13. Data are presented as mean ± SEM. * indicates significance from control
















Figure 3.6. Percent weight of testes expressed as a percentage of body weight in Lean 
and Obese Zucker control rats (A) and Obese Zucker rats (B) treated with NA ginseng or 
vehicle for 50 days (250 mg/kg). Number of animals per group: Control group: n = 10, 
Treatment group: control: n = 12, aqueous: n = 12, ethanol: n = 13. Data are presented as 
mean ± SEM. * indicates significance from control group within each test.
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3.4. Discussion
The results of the current study show improved erectile function with chronic 
administration of NA ginseng during copulation and ex copula reflex tests in OZ rats with 
impaired sexual function. Specifically, ethanol and aqueous extracts of NA ginseng 
treatment improved copulation efficiency, which is a measure of erectile function (Clark, 
1995), without significantly altering other parameters of sexual performance. Moreover, 
in ex copula reflex tests, ethanol extract increased the display of intense erections (cups), 
which are associated with increased intracavemosal pressure with flaring of the tip of the 
penile glans (Bemabe et al., 1995). In penile tissue, chronic treatment of ethanol, but not 
aqueous, extract increased nNOS mRNA while acute treatment increased eNOS mRNA. 
Finally, both extracts of NA ginseng treatment reduced weight gain after 25-33 days of 
treatment, which persisted throughout the remainder of the study.
The OZ rat is a well established model of pre-diabetes, and shares similar 
secondary pathologies as T2DM patients (Kasiske et al., 1992; Hidalgo-Tamola and 
Chitaley, 2009). These secondary pathologies, such as obesity, insulin resistance, 
decreased testosterone, and impaired vasodilation, contribute to ED (Edmonds and 
Withyachumnamkul, 1980; Withyachumnamkul and Edmonds, 1982; Doherty et al., 
1985; Hemmes and Schoch, 1988). Likewise, male OZ rats display an impaired initiation 
of sexual behavior (Withyachumnamkul and Edmonds, 1982), decreased intromission 
frequency (Doherty et al., 1985), decreased ejaculation latency (Doherty et al., 1985), or 
were unsuccessful at initiating mating (Young et al., 1986). The current results are in
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agreement with these studies. OZ rats were significantly impaired in most parameters of 
sexual behavior, including initiation of mating and measures of erectile function.
PDE5 inhibitors are currently the main treatment for ED. However, diabetic men 
have a diminished response to PDE5 inhibitors (Rendell et al., 1999). As such, the 
decrease in efficacy of PDE5 inhibitors in the diabetic population necessitates alternate 
treatments. Novel treatments have been tested to improve erectile function using rat 
models with T2DM (Garcia et al., 2009; Wingard et al., 2009). In particular, Zucker 
diabetic rats injected with a single dose of adipose-derived stem cells in the penis 
displayed greater intracavemous pressure (ICP) upon electrostimulation than control rats 
(Garcia et al., 2009). Also, Rosuvastatin, injected intraperitoneally for three days, 
improved erectile response to electrostimulation compared to control (Wingard et al.,
2009). Although improved erectile function was not observed during mating, these 
studies provide pharmacological treatment options for restoring erectile function in 
diabetic populations. The current study demonstrated that NA ginseng can provide an 
additional pharmacological option for ED treatment, as erectile function during mating as 
well as in reflex tests was improved.
The current data showed differing effects of NA ginseng extracts on enhancing 
erectile function in OZ rats. Although both extracts improved copulation efficiency 
during mating, only ethanol extract improved ex copula reflexes. A previous study from 
our laboratory also detected differing effects of the two extracts and showed that ethanol, 
but not aqueous, extract improved erectile function during mating behavior in healthy,
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young, adult Long Evans rats (Barnes et al., 2011). Other research studies have reported 
differing effects of ginseng on immunomodulation and cardiovascular effects based on 
the solvent used to create the extract (Lee et al., 1981; Azike et al., 2011). Ginsenoside 
profiles differ between extracts due to the solubilities of the ginsenosides in either ethanol 
or aqueous solutions (Azike et al., 2011). The ethanol extract used in this study has a 
higher percentage of ginsenoside content compared to the aqueous extract (approximately 
28% to 14% dry weight, respectively) (Azike et al., 2011), including slight differences in 
levels of Rbl. Ginsenoside Rbl did not prevent male mice copulatory disorder based on 
measuring latencies and frequencies of sexual performance parameters (Yoshimura et a l, 
1998); however, effects on erectile function have not been studied and cannot be ruled 
out. Ginsenoside Rgl has been shown to improve male sexual performance (Wang et al.,
2010) but difference in concentration between extracts did not reach significance, thus, it 
is unlikely to contribute to pro-erectile effects. The four remaining major ginsenosides of 
the two extracts used in this study have not been tested for enhancing male sexual 
function. A final contribution to the differences in effects between extracts may be due to 
polysaccharides (PS). PS differ been the extracts used in this study; the aqueous extract 
had detectable levels while the ethanol extract did not (Azike et al., 2011). PS in aqueous 
extracts are believed to contribute to the pro-inflammatory response that increased NO 
levels in macrophages while the lack of PS and increased ginsenoside concentrations in 
ethanol extracts caused an anti-inflammatory response (Azike et al., 2011). As such, the 
low levels of ginsenosides in the aqueous extract may be partially compensated by its 
pro-inflammatory response in regards to increasing erectile function while the ethanol
extract increases erectile function through alternate mechanisms possibly involving 
central and peripheral sites of action (Barnes et al., 2011).
The mechanisms through which the ethanol extract of NA ginseng elicits its 
effects on erectile function in OZ rats are unknown. A combination of factors contribute 
to the development of ED in OZ rats, including obesity, impaired vasodilation, and 
hyperglycemia (Gur et al., 2009; Hidalgo-Tamola and Chitaley, 2009). Villalba et al. 
have shown vascular remodelling of penile arteries in OZ rats alongside increased 
contractile response to high potassium-saline solutions and decreased endothelium- 
dependent relaxation to acetylcholine (Villalba et al., 2009). NO levels are reduced in OZ 
rat arteries concomitant to reduced endothelium-dependent relaxation, which occurred 
with vascular remodelling (Bouvet et al., 2007). Furthermore, decreased levels of 
antioxidants and increased production of ROS, which scavenge NO in the vasculature 
and decrease its bioavailability, are associated with vascular dysfunction in T2DM 
(Katakam et al., 2005; Hidalgo-Tamola and Chitaley, 2009). Treatment with antioxidants 
can partially rescue contractile responses in penile arteries of OZ rats (Villalba et al., 
2009). In conclusion, the above changes in the vasculature influence the NO/cGMP 
pathway required for proper erectile function (Rajfer, 2008) and these physiological 
changes provide mechanisms through which diabetic individuals can develop ED. In 
agreement with the present results, changes in total penile eNOS have not been detected 
in OZ rats compared to control (Villalba et al., 2009). Furthermore, our results do not 
indicate changes in either eNOS or nNOS mRNA in penile tissue of OZ rats compared to 
LZ rats. Conversely, decreased protein levels of both eNOS and nNOS in penile tissue
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were detected in male rats with streptozotocin-induced T2DM (Chiou et al., 2009) or 
genetic models of T2DM (Jesmin et al., 2003). It appears that changes in eNOS and 
nNOS mRNA or protein levels may appear with increased severity of T2DM, as in the 
current study OZ males were pre-diabetic and did not yet require insulin treatment. As 
such, deregulation of eNOS and nNOS in penile tissue may not yet be established.
The current results demonstrate that ethanol, but not aqueous extract of NA 
ginseng increased eNOS and nNOS mRNA expression in penile tissues of OZ males. 
nNOS mRNA content was increased with chronic administration of ethanol extract while 
eNOS mRNA appears to be increased acutely (one hour). Recent findings from our 
laboratory show healthy, young, adult Long Evens rats administered ethanol extract of 
NA ginseng had increased eNOS and nNOS mRNA in penile tissue (Bames et al., 2011). 
Interestingly, both eNOS and nNOS mRNA in our previous study were increased only 
with acute dosing while in this study nNOS is increased with chronic treatment and 
eNOS by acute treatment. Reasons for the difference can only be speculated. Healthy 
Long Evans rats may have tighter control of mRNA expression in penile tissue, thus, 
nNOS mRNA content is rapidly brought to homeostatic levels, whereas in pre-diabetic 
models, OZ rats may not possess such control. Furthermore, induction of mRNA, such as 
nNOS, persists over a longer period. Indeed, mRNA levels of genes associated with 
cardiovascular regulation have been shown to be increased or decreased in diabetic 
models and may be deregulated compared to healthy controls (Banz et al., 2007; Keller 
and Attie, 2010).
The mechanism through which eNOS or nNOS mRNA is increased is unknown. 
Rbl, which is present in higher concentrations in the ethanol extract, and its metabolite 
(compound K) have both been shown to increase eNOS phosphorylation and activity (Yu 
et al., 2007; Tsutsumi et al., 2011). As such, Rbl may enhance the NO/cGMP pathway in 
penile vasculature, which is required for reversal of ED in diabetes (Angulo et al., 2005). 
In addition, ginsenoside Rd, among many other ginsenosides, has been shown to increase 
antioxidant enzymes and decrease oxidative stress (Yokozawa et al., 2004; Ye et al.,
2011). As such, Rd may protect the vasculature from the oxidative stress that has been 
linked to ED in diabetes (Hidalgo-Tamola and Chitaley, 2009). In conclusion, it is 
possible that NA ginseng treatment caused enhanced vasodilation and protection from 
oxidative stress, resulting in partial recovery of erectile function in OZ rats.
However, improvement of erectile function during mating behavior appeared to 
occur independent of changes in eNOS or nNOS, since aqueous extract improved sexual 
behavior without affecting levels of NOS. Hence, other factors must contribute to the 
facilitative actions of NA ginseng on erectile function. Such factors do not appear to 
involve increased production of testosterone. Circulating testosterone levels have been 
shown to be decreased in OZ rats (Whitaker et a l, 1983). However, even though the 
testicular weight, as a percent of total body weight, was increased with ethanol extract 
treatment (indicating a potential increase in plasma testosterone levels), plasma 
testosterone was not significantly affected by NA ginseng treatment. This is in agreement 
with a study by Murphy and colleagues testing NA ginseng on male sexual behavior; no 
effect of NA ginseng on plasma testosterone levels was measured (Murphy et al., 1998).
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Hence, it is unlikely that NA ginseng improves sexual function by increasing testosterone 
production. Other factors that may have contributed to the action of NA ginseng in OZ 
rats include actions on the central nervous system (Barnes et al, 2011) and future studies 
are needed to test that hypothesis.
In conclusion, this study provides evidence for using the ethanol extract of NA 
ginseng to partially rescue erectile function in pre-diabetes. The ethanol extract was able 
to moderately enhance erectile function during mating and in an ex copula reflex test. As 
such, NA ginseng may provide an additional pharmacological treatment for men with 
diabetic complications that experience ED.
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The results of these studies provide evidence of the pro-erectile effects of NA 
ginseng in healthy and pre-diabetic male rats. Previous studies have shown that Asian 
ginseng and ginsenoside Rgl treatment have pro-erectile properties by acting on the 
NO/cGMP pathway (Chen and Lee, 1995; Wang et al., 2010); however effects of NA 
ginseng on erectile function have not been investigated. One goal of this study was to 
characterize two common extracts of NA ginseng. Indeed, different effects were found; 
the ethanol extract enhances erectile function while the aqueous extract provided little to 
no effect. An additional goal was to determine potential mechanisms through which NA 
ginseng produces pro-erectile effects. We have shown a central action of NA ginseng as 
indicated by an increase of nNOS in the PVN (Chapter 2) as well as a peripheral action as 
indicated by increasing eNOS and nNOS mRNA in penile tissue in healthy (Chapter 2) 
and pre-diabetic male rats (Chapter 3).
Chapter 2 revealed increased eNOS and nNOS mRNA one hour after injection but 
no effect of chronic treatment. In contrast, increased nNOS occurred in chronically 
treated pre-diabetic rats while eNOS was dependent on final injection, similar to the 
healthy rats (Chapter 3). The reasons for the differences in mRNA content increases 
between healthy and pre-diabetic rats can only be speculated since neither the active 
constituent nor the receptor activating gene transcription is known. Transcription 
deregulation has been shown in diabetic populations for genes of transcription factors
from overexposure to cytotoxic fatty acids (Johnstone et al., 2011) and cellular 
messengers involved in gene transcription for inflammatory responses (Siqueira et al., 
2010). As such, the induction of mRNA transcription of nNOS in healthy rats may be 
quickly regulated to homeostatic levels within 24 hours whereas in pre-diabetic rats, the 
increase in nNOS is not as tightly regulated so chronic ethanol extract administration 
increases nNOS mRNA levels, which remain high over 24 hours.
The current study has limitations when explaining the ability of NA ginseng to 
enhance erectile function. Firstly, this study only measured levels of eNOS and nNOS 
mRNA content in penile tissue. These levels may not translate into increased protein 
content. Furthermore, the protein content may not correlate to NO activity and, as such, 
further studies are needed to determine NO activity in penile and brain tissue of NA 
ginseng-treated rats. In addition, a time course for NA ginseng’s effects at improving 
erectile function and NO modulation are required; however, these objectives were outside 
of the scope of the current study. Finally, pathways through which NA ginseng produces 
effects on sexual performance need to be discovered to calculate appropriate dosing.
Although effects were detected on the NO/cGMP pathway in penile tissue and on 
nNOS expression in the PVN, a disconnect exists between these effects and the 
enhancement of erectile function. NA ginseng was able to increase eNOS and nNOS 
mRNA content in the penis and nNOS immunoreactivity in the PVN after one hour of 
dosing without any effects of chronic treatment. Conversely, NA ginseng was able to 
increase CE with chronic treatment where dosing did not occur for 24 hours before
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testing. As such, although NO activity may contribute to some parameters of sexual 
behavior, other mechanisms must exist.
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Alternate mechanisms through which NA ginseng may be producing its effects 
include activating other mediators of erection in supraspinal regions such as dopamine 
and influencing spinal cord modulation. Ginseng has already been shown to modulate 
dopamine release when administered with drugs of abuse (Shim et al., 2000; Kim et al., 
2006; Lee et al., 2008). Dopamine has a pro-erectile effect on brain regions including the 
PVN (Baskerville et al., 2009). Furthermore, increased dopamine has been indirectly 
attributed to improvements of male sexual behavior in NA ginseng-treated rats (Murphy 
et al., 1998) and effects in this current study may be occur due to influences on the 
dopamine system. In addition, although NA ginseng has not been shown to affect spinal 
control of erections, it cannot be ruled out as a possible site of action. The spinal cord 
directly controls erectile response in males (McKenna, 2000) so any influence on the 
erectile pathway may enhance erectile response.
Since increased eNOS or nNOS mRNA or protein occurred with NA ginseng 
injections one hour prior to measurements but did not translate to increased in copula 
performance in healthy rats, it is possible that small improvements of erectile mediators 
can affect ex copula reflexes but are insufficient to influence mating for which much 
more erectile improvement is required. Indeed, in copula erectile function is mediated by 
a complex interplay of neurochemical and hormonal inputs (Pfaus et al., 2001). Future 
studies can investigate telemetry of the cavemosal bodies during copulation to determine
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if penile rigidity is increased during mating even if measures of sexual behavior do not 
indicate increased erectile function. In addition, tests of telemetry of the corpus 
cavemosum in anesthetised rats would help determine if acute (and chronic) NA ginseng 
administration increases intracavemous pressure during electrostimulation. These 
experiments would help determine the contribution of the NO/cGMP pathway in NA 
ginseng’s pro-erectile effects.
Ginsenosides, regardless of their very low oral bioavailability, are detected in the 
blood of canines after oral administration 10 minutes after injection (Song et a l, 2010).
In addition, although ginsenosides are not NO donors, they cause an increase in corpus 
cavemosum relaxation and cGMP levels with 10 minutes of exposure (Chen and Lee, 
1995; Murphy and Lee, 2002). As such, the rapid effects of ethanol extract on increased 
mRNA content after administration seem to be physiologically possible within one hour 
of injection.
The ginsenoside(s) responsible for the increase in erectile function and cellular 
mediators of erectile function with acute NA ginseng treatment must be rapidly absorbed 
and reach concentrations necessary to produce their effects. Ginsenosides are divided into 
two groups based on their structures: 20(S)-protopanaxadiol (ppd) ginsenosides have 
sugar moieties at either C-3, C-20, or both positions while 20(S)-protopanaxatriol (ppt) 
ginsenosides have a hydroxyl group at C-3 and sugar moieties at C-6, C-20, or both 
(Attele et a l, 1999). Ppd-ginsenosides include Rbl and Rd while ppt-ginsenosides 
include Rgl and Re (Gillis, 1997). Notably, the ethanol extract used in this study has
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increased levels of Rbl and Rd. Intestinal absorption of ginsenosides occurs largely via 
passive diffusion and, as such, ppd-ginsenosides have greater intestinal absorption and 
systemic exposure due to their smaller molecular size and lipid solubility (Liu et a l, 
2009). Also, ppd-ginsenosides have a much greater half-life compared to ppt- 
ginsenosides (13-18 hours compared to <4 hours, respectively) and were detectible in 
plasma 48 hours after oral administration (Liu et al., 2009). Even though the time to 
maximal plasma concentration for ppd-ginsenosides does not occur until 6-10 hours after 
oral injection, they provide the best targets for increasing erectile function after 30 
minutes of dosing (with naïve pre-diabetic rats and ex copula tests) and cellular mediators 
after one hour of dosing. In addition, given their long half-life they also provide the best 
candidates for producing chronic effects of increased in copula erectile function in 
healthy and pre-diabetic rats (after sexual experience). Furthermore, since both ppd- 
ginsenosides Rbl and Rd differ between ethanol and aqueous extracts and are part of the 
six ginsenosides that constitute over 70% of the ginsenoside content of NA ginseng (Lim 
et a l, 2005), they provide the best candidates for producing the pro-erectile effects seen 
in the ethanol extract.
The metabolite of ginsenoside Rbl, Compound K, which is the main form 
absorbed after intestinal bacteria metabolism, has been shown to phosphorylate and 
active eNOS in vivo (Tsutsumi et a l, 2011). In penile tissue, increased eNOS activity 
would lead to increased production of cGMP through increased NO levels, which would 
contribute to erection induction. In addition, ginsenoside Rbl has anti-diabetic and 
insulin-sensitizing effects; Rbl stimulated glucose transport by promoting the
translocation of GLUT1 and GLUT 4 (Shang et al., 2007; Shang et al., 2008). 
Furthermore, given the long half-life of Rbl, any improvement in diabetic symptoms 
could cause long-term improvements that reduce the intensity of secondary pathologies 
of diabetes and, alongside increased in eNOS phosphorylation, it may contribute to pro- 
erectile effects. In addition, ginsenoside Rd which is also a ppd-ginsenoside, increases 
endogenous oxidative defences in senescence mice by improving the 
glutathione/glutathione disulphide ratio and decreasing markers of lipid peroxidation 
(Yokozawa et al., 2004). As such, with increased endogenous scavenging for ROS, more 
NO is free to act on penile smooth muscle cells to induce penile erections with 
ginsenoside Rd treatment (Hidalgo-Tamola and Chitaley, 2009).
In regards to ppt-ginsenosides, ginsenoside Rgl may be able to further increase 
NO production which it has been shown in bovine aortic endothelial cells (Kim et al., 
1992) and in penile tissue alongside increased measures of sexual performance (Wang et 
al., 2010). The increase in NO production would not be scavenged by ROS due to the 
antioxidant effects of ginsenosides Rd and Rbl. One final consideration for the 
differences between extracts, the ethanol extract may provide the minimum effective dose 
(MED) required for pro-erectile effects given that its ginsenoside concentration is greater 
(28%) than the aqueous extract (14%). If multiple ginsenosides are able to meet the MED 
required then synergistic, pro-erectile effects of NA ginseng can contribute to the 
improvements of erectile function in copula and during reflex tests seen in this study.
I l l
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Ginseng extracts have been shown to improve self-reported measures of erectile 
function in humans and improve erection rigidity while men were exposed to audio and 
visual stimulation (Hong et al., 2002; Jang et al., 2008). However, NA ginseng has not 
been tested in human populations. The results of this study indicate a potential for ethanol 
extract of NA ginseng to improve erectile function in healthy and diabetic human 
populations with ED. Given that a greater proportion of diabetic men do not report 
positive responses to PDE5 inhibitors (Rendell et al., 1999), NA ginseng may provide 
another pharmacological treatment option and is well tolerated with reports of a few mild 
side effects (Gillis, 1997). A combination therapy of NA ginseng with PDE5 inhibitors 
may provide addition benefits over PDE5 inhibitors alone. In summary, NA ginseng can 
increase endogenous production of NO and therefore cGMP content while PDE5 
inhibitors prevent the degradation of cGMP. As such, cGMP can activate the cellular 
mediators needed to initiate an erection.
In conclusion, the results of this study demonstrated the effects of two NA 
ginseng extracts on erectile function and sexual behavior in healthy and pre-diabetic rats 
with ED. Moreover, ethanol extract of NA ginseng was successful at increasing erectile 
function in copula in healthy rats with both central (PVN) and peripheral (penile tissue) 
sites of action. In pre-diabetic rats, ethanol extract increased erectile function in copula as 
well as penile reflexes with a peripheral site of action (penile tissue), although central 
sites of actions were not investigated. In summary, ethanol extract of NA ginseng can be 
used for enhancing erectile function in healthy or pre-diabetic male rats and future tests 
may show a translation to increased erectile function in humans.
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